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Abstract
Dangerous damage to mitochondrial DNA (mtDNA) can be
ameliorated during mammalian development through a highly
debated mechanism called the mtDNA bottleneck. Uncer-
tainty surrounding this process limits our ability to address
inherited mtDNA diseases. We produce a new, physically
motivated, generalisable theoretical model for mtDNA popu-
lations during development, allowing the first statistical com-
parison of proposed bottleneck mechanisms. Using approx-
imate Bayesian computation and mouse data, we find most
statistical support for a combination of binomial partitioning
of mtDNAs at cell divisions and random mtDNA turnover,
meaning that the debated exact magnitude of mtDNA copy
number depletion is flexible. New experimental measure-
ments from a wild-derived mtDNA pairing in mice confirm
the theoretical predictions of this model. We analytically
solve a mathematical description of this mechanism, comput-
ing probabilities of mtDNA disease onset, efficacy of clinical
sampling strategies, and effects of potential dynamic inter-
ventions, thus developing a quantitative and experimentally-
supported stochastic theory of the bottleneck.
Mitochondria are vital energy-producing organelles within
eukaryotic cells, possessing genomes (mitochondrial DNA or
mtDNA) that replicate, degrade and develop mutations [1,
2]. MtDNA mutations have been implicated in numerous
pathologies including fatal inherited diseases and ageing [3,
4, 5, 1]. Combatting the buildup of mtDNA mutations is
of paramount importance in ensuring an organism’s survival.
Substantial recent medical, experimental and media attention
focused on methods to remove [6] or prevent the inheritance
of [7, 8, 5, 9, 10] mutated mtDNA in humans.
One means by which organisms may ameliorate the mtDNA
damage that builds up through a lifetime is through a devel-
opmental process known as bottlenecking. Immediately after
fertilisation, a single oocyte (which may contain > 105 indi-
vidual mtDNAs) may have a nonzero mtDNA mutant load
or heteroplasmy (the proportion of mutant mtDNA in the
cell). As the number of cells in the developing organism in-
creases, the intercellular population will then acquire an asso-
ciated heteroplasmy variance, that is, the variance in mutant
load across the population of cells (Fig. 1A), allowing re-
moval of cells with high heteroplasmy and retention of cells
with low heteroplasmy. Intense and sustained debate exists
as to the mechanism by which this increase of heteroplasmy
variance occurs. Several experimental results in mice sug-
gest that, during development, the copy number of mtDNA
per cell in the germ cell line drops dramatically to ∼ 102, re-
ducing the effective population size of mitochondrial genomes
[11, 12]. One postulated bottlenecking mechanism is that this
low population size accelerates genetic drift and so increases
the cell-to-cell heteroplasmy variance [11, 13, 14, 15], which
was first observed to generally increase from primordial germ
cells through primary oocytes to mature oocytes [16]. How-
ever, independent experimental evidence [12] suggests that
heteroplasmy variance increases negligibly during this copy
number reduction, though this interpretation has been de-
bated [17]. Ref. [12] shows heteroplasmy variance rising dur-
ing folliculogenesis, after the mtDNA copy number minimum
has been passed. In yet another picture, supported by con-
flicting experimental results [18, 19], heteroplasmy variance
increases with a less pronounced decrease in mtDNA copy
number (a minimum copy number > 103 in mice), solely
through random effects associated with partitioning at cell
divisions. Clearly a consensus on this important mechanism
is yet to be reached.
Important existing theoretical work on modelling the bot-
tleneck has assumed a particular underlying mechanism [13,
20] or derived statistics of mtDNA populations [21, 14, 22, 23]
without explicitly considering changing mtDNA population
size, or the discrete nature of the mtDNA population: effects
which may powerfully affect mtDNA statistics. To capture
these effects it is necessary to employ a ‘bottom-up’ physical
description of mtDNA as populations of individual, discrete
elements subject to replication and degradation, as in, for ex-
ample, Refs. [21] and [24]. Exploring the bottleneck also re-
quires explicitly modelling partitioning dynamics throughout
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a series of cell divisions, over which population size can change
dramatically. While previous simulation work [11, 25] has
taken such a philosophy with specific model assumptions, we
are not aware of such a study allowing for the wide variety of
replication and partitioning dynamics proposed in the litera-
ture; we further not that replication-degradation-partitioning
mtDNA models are yet to be fully described analytically. Nor
is there a general quantitative framework under which dif-
ferent proposed bottleneck mechanisms can be statistically
compared given extant data (although statistical analyses fo-
cusing on particular mechanisms and individual sets of exper-
imental results have been used throughout the literature, for
example, using a Bayesian approach under a particular bot-
tleneck model to infer model bottleneck size [26]). Combined
developments in theory and inference are therefore required
to make progress on this important question.
We remedy this situation by constructing a general model
(features and parameters described in Fig. 1) for the popu-
lation dynamics of the bottleneck, able to describe the range
of proposed mechanisms existing in the literature. Using ex-
perimental data on mtDNA statistics through development
[16, 11, 12, 18], we use approximate Bayesian computation
[27, 28, 29, 30] to rigorously explore the statistical support for
each mechanism, showing that random mtDNA turnover cou-
pled with binomial partitioning of mtDNAs at cell divisions
is highly likely, and that the debated magnitude of mtDNA
copy number reduction is somewhat flexible. Subsequently,
we confirm the predictions of this model by performing new
experimental measurements of heteroplasmy statistics in mice
with an mtDNA admixture, including a wild-derived haplo-
type, that is genetically distinct from previous studies. We
then analytically solve the equations describing mtDNA pop-
ulation dynamics under this mechanism and show that these
results allow us to investigate potential interventions to mod-
ulate the bottleneck (suggesting that upregulation of mtDNA
degradation may increase the power of the bottleneck to avoid
inherited disease; we discuss potential strategies for such an
intervention) and yield quantitative results for clinical ques-
tions including the timescales and probabilities of disease on-
set, and the efficacy of strategies to sample heteroplasmy in
clinical planning.
Results
A general mathematical model encompassing
proposed bottlenecking mechanisms
We will consider three different classes of proposed generat-
ing mechanisms for the mtDNA mechanisms: namely, those
proposed in Cree et al. [11]; Cao et al. [18] and Wai et al.
[12]. We will refer to these mechanisms by their leading au-
thor name. The Cree mechanism involves random replication
and degradation of mtDNAs throughout development, and
binomial partitioning of mtDNAs at cell divisions. The Cao
mechanism involves partitioning of clusters of mtDNA at each
cell division, thus providing strong stochastic effects associ-
ated with each division. We consider a general set of dynamics
through which this cluster inheritance may be manifest, in-
cluding the possibility of heteroplasmic ‘nucleoids’ of constant
internal structure [31], sets of molecules or nucleoids within an
organelle, homoplasmic clusters, and different possible cluster
sizes (see Supplementary Information). The Wai mechanism
involves the replication of a subset of mtDNAs during follicu-
logenesis. We note that this latter mechanism can be mani-
fest in several ways: (a) through slow random replication of
mtDNAs (so that, in any given time window, only a subset
of mtDNAs will be actively replicating) or (b) through the
restriction of replication to a specific subset of mtDNAs at
some point during development. We will refer to these differ-
ent manifestations as Wai (a) and Wai (b) respectively. The
Wai (a) mechanism and the Cree model can both be addressed
in the same mechanistic framework (with potentially differ-
ent parameterisations): if the rate of random replication in
the Cree model is sufficiently low during folliculogenesis, only
a subset of mtDNAs will be actively replicating at any given
time during this period, thus recapitulating the Wai (a) mech-
anism (see Supplementary Information). We will henceforth
combine discussion of the Wai (a) and Cree mechanisms into
what we term the birth-death-partition (BDP) mechanism.
We seek a physically motivated mathematical model for
the bottleneck that is capable of reproducing each of these
mechanisms. Our general model for the bottleneck (detailed
description in Methods) involves a ‘bottom-up’ representa-
tion of mtDNAs as individual intracellular elements capa-
ble of replication and degradation (Fig. 1B) with rates λ
and ν respectively. A parameter S determines whether these
processes are deterministic (specific rates of proliferation) or
stochastic (replication and degradation of each mtDNA is
a random event). These rates of replication and degrada-
tion of mtDNA are likely strongly linked to mitochondrial
dynamics within cells, through the action of mitochondrial
quality control [32, 33] modulated by mitochondrial fission
and fusion [34, 35, 36], which can act to recycle weakly-
perfoming mitochondria [37, 38]. This quality control can be
represented through the degradation rates assigned to each
mtDNA species, which may differ (for selective quality con-
trol) or be identical (for non-selective turnover).
The proportion of mtDNAs capable of replication is con-
trolled by a parameter α in our model, dictating the pro-
portion of mtDNAs that may replicate after a cutoff time T .
Thus, if α = 1, all mtDNAs may replicate; if α < 1, replica-
tion of a subset proportion α of mtDNAs is enforced at this
cutoff time. At cell divisions, mtDNAs may be partitioned
either deterministically, binomially, or in clusters according
to a parameter c (Fig. 1C).
The copy number of mtDNA per cell is observed to vary
dramatically during development, with dynamic phases of
copy number depletion and different rates of subsequent re-
covery observed. Additionally, cell divisions occur in the
germline at different rates during development, with cells
becoming largely quiescent after primary oocytes develop.
To explicitly model these different dynamic regimes, and
the behaviour of mtDNA copy number during each, we in-
clude six different dynamic phases throughout development,
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Figure 1: The mitochondrial bottleneck, and elements of a general model for bottlenecking mechanisms. (A) The mtDNA
bottleneck acts to produce a population of oocytes with varying heteroplasmies from a single initial oocyte with a specific heteroplasmy value.
During development, mtDNA copy number per cell decreases (by a debated amount, which we address; see Main Text) then recovers, suggesting
a ‘bottleneck’ of cellular mtDNA populations. (B) Cellular mtDNA populations during the bottleneck are modelled as containing wildtype and
mutant mtDNAs. MtDNAs can replicate and degrade within a cell cycle, with rates λ and ν respectively. (C) At cell divisions, the mtDNA
population is partitioned between two daughter cells either deterministically, binomially, or through the binomial partitioning of mtDNA clusters.
(D) Symbols used to represent quantities and model parameters used in the main text, and their biological interpretations.
each with different rates of replication and degradation (la-
belled with subscript i labelling the dynamic phase: hence
λ1, ν1, ..., λ6, ν6), and allowing for different rates of cell di-
vision or quiescence. This protocol enables us to explicitly
model effects of changing population size throughout devel-
opment rather than assuming dependence on a single, coarse-
grained effective population size; and to include the effects
of specific and varying cell doubling times. A summary of
symbols used in our model and throughout this article is pre-
sented in Fig. 1D.
Our model, with suitable parameterisation, can thus mirror
the dynamics of the Cree and Wai (a) mechanisms (stochas-
tic dynamics and binomial partitioning, which we refer to as
the BDP mechanism); the Cao mechanism (clustered parti-
tioning); and Wai (b) mechanism (deterministic dynamics,
restricted subset of replicating mtDNAs). The Cao mech-
anism, partitioning of clusters of mtDNA molecules, repre-
sents the expected case if mtDNA is partitioned in colocalised
‘nucleoids’ within each organelle (or in other sub-organellar
groupings). The size of mtDNA nucleoids is debated in the
literature [1, 39, 40] (although recent evidence from high-
resolution microscopy suggests that nucleoid size is gener-
ally < 2 [41], consonant with recent evidence that individual
nucleoids may be homoplasmic [42]); our model allows for
inheritance of homoplasmic or heteroplasmic nucleoids of ar-
bitrary characteristic size c, thus allowing for a range of sub-
organellar mtDNA structure. We discuss the impact of mixed
or fixed nucleoid content in the Supplementary Information.
A birth-death-partition model of mtDNA dy-
namics has most statistical support given ex-
perimental measurements
We take data on mtDNA copy number in germ line cells in
mice from three recent experimental studies [11, 18, 12]. We
also use data from two experimental studies on heteroplasmy
variance in the mouse germ line during development [16, 12].
This data, by convention [17], is normalised by heteroplasmy
level h, giving
V′(h) =
V(h)
E(h)(1− E(h)) , (1)
where normalised variance V′(h) is a quantity that will be
often used subsequently. This normalised variance controls
for the effect of different or changing mean heteroplasmy, and
thus allows a comparison of heteroplasmy variance among
samples with different mean heteroplasmies and subject to
heteroplasmy change with time. We use a time of 100 dpc to
correspond to mature oocytes (see Methods). These hetero-
plasmy variance studies employ intracellular combinations of
the same pairing of mtDNA haplotypes (NZB and BALB/c),
modelling two different mtDNA types within a cellular pop-
ulation. We take data on cell doubling times from a classical
study [43] (see Methods). A possible summary of these data
(although they provoke ongoing debate; see Discussion) is
that, as shown in Fig. 2A, the existing data on normalised
heteroplasmy variance shows initially low variance until ∼ 7.5
dpc (days post conception, which we use as a unit of time
throughout), rising to intermediate values between 7.5 and
21 dpc, gradually rising further subsequently to become large
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Figure 2: Different mechanisms for the mtDNA bottleneck.
(A) Trajectories of mean copy number E(m) and normalised hetero-
plasmy variance V(h) arising from the models described in the text,
optimised with respect to data from experimental studies. BDP denotes
the birth-death-partition model, encompassing Cree and Wai (a) mecha-
nisms. Left plots show trajectories during development; right plots show
behaviour in mature oocytes in the next generation. * denotes measure-
ments in mature oocytes, modelled as 100 dpc (see Methods). (B) Statis-
tical support for different mechanisms from approximate Bayesian com-
putation (ABC) model selection with thresholds 1,2,3,4 = 75, 60, 50, 45.
As the threshold decreases, forcing a stricter agreement with experi-
ment (thinner, darker columns), support converges on the birth-death-
partitioning (BDP) model.
in the mature oocytes of the next generation. In Fig. 2A, and
throughout this article, experimentally measured data will be
depicted as circular points and inferred theoretical behaviour
will be depicted as lines or shaded regions.
Fig. 2A shows mtDNA population dynamic trajectories re-
sulting from optimised parameterisations of each of the mech-
anisms we consider (see Methods). In Fig 2B we show poste-
rior probabilities on each of these mechanisms. These poste-
rior probabilities give the inferred statistical support for each
mechanism, derived from model selection performed with ap-
proximate Bayesian computation (ABC) [27, 28, 29, 30] us-
ing uniform priors. ABC involves choosing a threshold value
dictating how close a fit to experimental data is required
to accept a particular model parameterisation as reasonable.
In our case, this goodness-of-fit is computed using a com-
parison of squared residuals associated with the trajecto-
ries of mean mtDNA copy number and normalised hetero-
plasmy variance (see Methods and Supplementary Informa-
tion). Each of the experimental measurements corresponds
to a sample variance, derived from a finite number of samples
of an underlying distribution of heteroplasmies, and there-
fore has an associated uncertainty and sampling error [14].
The reasonably small sample sizes used in these sample vari-
ance measurements are likely to underestimate the underly-
ing heteroplasmy variance (the target of our inference). Our
ABC approach naturally addresses these uncertainties by us-
ing summary statistics derived from sampling a set of stochas-
tic incarnations of a given model, where the size of this set
is equal to the number of measurements contributing to the
experimentally-determined statistic (see Methods). Fig. 2B
clearly shows that as the ABC threshold is decreased, re-
quiring closer agreement between the distributions of simu-
lated and experimental data, the posterior probability of the
BDP model increases, to dramatically exceed those of the
other models. This increase indicates that the BDP model
is the most statistically supported, and capable of provid-
ing the best explanation of experimental data (which can be
inutitively seen from the trajectories in Fig. 2A). We note
that ABC model selection automatically takes model com-
plexity into account, and conclude that the BDP mechanism
is the best supported proposed mechanism for the bottleneck.
Briefly, this result arises because the BDP model produces in-
creasing variance both due to early cell division stochasticity
and later random turnover. By contrast, the Cao model alone
only increases variance in early development when cell divi-
sions are occurring. Qualitatively, this behaviour through
time holds regardless of cluster (nucleoid) size and regard-
less of whether clusters are heteroplasmic or homoplasmic
(allowing heteroplasmic clusters decreases the magnitude of
heteroplasmy variance but not its behaviour through time,
see Supplementary Information). The Wai (b) model alone
similarly only increases variance at a single time point (later,
during folliculogenesis).
In Ref. [12], visualisations of cells after BrU incorpora-
tion show that a subset of mitochondria retain BrU labelling,
which the authors suggest indicates that a subset of mtD-
NAs are replicating. In the Supplementary Information, we
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show that the BDP model also results in the observation of
only a subset of replicating mtDNAs over the timeframe cor-
responding to these experimental results. These observations
thus correspond to results expected from the random turnover
from the BDP model. We also note the mathematical obser-
vation that the Wai (b) mechanism requires the replication
of < 1% of mtDNAs during folliculogenesis to yield reason-
able heteroplasmy variance increases (Fig. 2A shows the op-
timal case with α = 0.006; optimal fits to data generally show
0.005 < α < 0.01), and the proportions of loci visible in Ref.
[12] are substantially higher than this required 1% value.
We show in the Supplementary Information that the het-
eroplasmy statistics corresponding to binomial partitioning
also describe the case where the elements of inheritance are
heteroplasmic clusters, where the mtDNA content of each
cluster is randomly sampled from the population of the cell
(either once, as an initial step, or repeatedly at each division).
This similarity holds broadly, regardless of whether the inter-
nal structure of clusters is constant across cell divisions or
allowed to mix between divisions. The BDP model, in ad-
dition to describing the partitioning of individual mtDNAs,
also thus represents the statistics of mtDNA populations in
which heteroplasmic nucleoids are inherited [31], or individ-
ual organelles containing a mixed set of mtDNAs or nucleoids
are inherited, regardless of the size of these nucleoids (see Dis-
cussion).
Parameterisation and interpretation of the
birth-death-partition model
Having used ABC model selection to identify the BDP model
as the most statistically supported, we can also use ABC to in-
fer the values of the governing parameters of this model given
experimental data. Figs. A and B shows the trajectories of
mean copy number and mean heteroplasmy variance resulting
from model parameterisations identified through this process.
Fig. C shows the inferred behaviour of mtDNA degradation
rate ν in the model, a proxy for mtDNA turnover (as the
copy number is constrained). Turnover is generally low dur-
ing cell divisions, allowing heteroplasmy variance to increase
due to stochastic partitioning. Turnover then increases later
in germ line development, resulting in a gradual increase of
heteroplasmy variance after birth until the mature oocytes
form in the next generation.
Fig. D shows posterior distributions on the copy number
minimum and total turnover (see Methods) resulting from
this process; posteriors on all other parameters are shown
in Supplementary Information. Substantial flexibility exists
in the magnitude of the copy number minimum, illustrating
that observed heteroplasmy variance can result from a range
of bottleneck sizes from ∼ 200 to > 103; going some way
towards reconciling the conflict between Refs. [18] and [19]
and Refs. [11] and [12]. The total amount of mtDNA turnover
(presented as σ =
∑6
i=3 νiτ
′
i , the product of turnover rate and
the time for which this rate applies, summed over quiescent
dynamic phases; for example, a turnover rate of 0.1 hr−1 for
30 days yields σ = 0.1 × 24 × 30 = 72) is constrained more
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Figure 3: Parameterisation of the BDP model and inferred
details of bottleneck mechanism. Trajectories of (A) mean copy
number E(m) and (B) normalised heteroplasmy variance V′(h) resulting
from BDP model parameterisations sampled using ABC with a thresh-
old  = 40. * denotes measurements in mature oocytes, modelled as
100 dpc (see Methods). Note: the range in (B) does not correspond
to a credibility interval on individual measurements, but rather on an
expected underlying (population) variance, from which individual vari-
ance measurements are sampled. We thus expect to see, for example,
several measurements lower than this range due to sampling limita-
tions (see text). (C) Posterior distributions on mtDNA turnover ν with
time. (D) Posterior distribution on min E(m), the minimum mtDNA
copy number reached during development. (E) Posterior distribution on
σ =
∑6
i=3 τ
′
iνi, a measure of the total amount of mtDNA turnover.
than the specific trajectory of mtDNA turnover rates, showing
that a variety of time behaviours of turnover are capable of
producing the observed heteroplasmy behaviour.
Experimental verification of the birth-death-
partition model
The bottleneck mechanism identified through our analysis has
several characteristic features which facilitate experimental
verification. Key among these are the prediction that hetero-
plasmy variance acquires an intermediate (nonzero, but not
maximal) value as a result of the copy number bottleneck,
then continues to increase due to mtDNA turnover in later
development. Our theory also produces quantitative predic-
tions regarding the structure of heteroplasmy distributions at
arbitrary times.
The existing data that we used to perform inference and
model selection display a degree of internal heterogeneity,
coming from several different experimental groups. Further-
more, these data represent statistics resulting from a single
pairing of mtDNA types, and it is thus arguable how conclu-
sions drawn from them may represent the more genetically
diverse reality of biology. Ref. [44] recently addressed the
issue of this limited number of mtDNA pairings by produc-
ing novel mouse models involving mixtures of standard and
several new, unexplored, wild-derived haplotypes which cap-
ture a range of genetic diversity. To test the applicability and
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generality of our predictions, we have perfomed new exper-
imental measurements of germline heteroplasmy variance in
these model animals under a consistent experimental protocol
(see Methods). We use the ‘HB’ mouse line from Ref. [44]
pairing a wild-derived mtDNA haplotype (labelled ‘HB’ after
its source in Hohenberg, Germany) with C57BL/6N; we refer
to this model as ‘HB’.
Heteroplasmy measurements were taken in oocytes sam-
pled from mice at ages 24-61dpc (see Methods and Supple-
mentary Information; raw data in Source data 1). The statis-
tics of these measurements yielded E(h), V(h) and V′(h) as
previously. This age range was chosen to address the regions
with most power to discriminate between the competing mod-
els; the existing V′(h) data is most heterogeneous around 20-
30dpc and the later datapoints allow us to detect developmen-
tal heteroplasmy behaviour after the copy number minimum.
Fig. A shows these V′(h) measurements. The qualitative be-
haviour predicted by the BDP mechanism is clearly visible:
variance around birth (after the copy number bottleneck) is
low but non-zero, subsequently increasing with time. The
ability of the BDP model to account for the magnitudes and
time behaviour of heteroplasmy variance more satisfactorily
than the alternative models is shown by the model fits in Fig.
A. We explored these new data quantitatively through the
same model selection approach used for the existing data. As
shown in Fig. B, the BDP mechanism again experiences by
far the strongest statistical support in this genetically differ-
ent system.
Fig. C shows the result of our parameteric inference ap-
proach using these V′(h) measurements coupled with the
E(m) measurements used previously (employing our assump-
tion that modulation of copy number by heteroplasmy in this
non-pathological haplotype is small). Strikingly, the quan-
titative behaviour of V′(h) with time inferred from the HB
model (red) matches the previous behaviour inferred from
the NZB/BALB/c system (blue) very well, suggesting that
our theory is applicable across a range of genetically distinct
pairings. We note that the shaded region in Fig. C corre-
sponds to credibility intervals around the mean behaviour of
V′(h), and the fact that individual V′(h) datapoints (subject
to fluctuations and sampling effects) do not all lie within these
intervals is not a signal of poor model choice. An analogous
situation is the observation of a scatter of datapoints outside
the range of the standard error on the mean (s.e.m.), which
does not imply a mistake in the s.e.m. estimate. The differ-
ence between the trace in Fig. A and the mean curve in Fig.
C arises because Fig. A shows the behaviour of the model
under a single, optimised parameterisation, whereas Fig. C
shows the distribution of model behaviours over the posterior
distributions on parameters: the mean V′(h) trace of this dis-
tribution is comparable but not equivalent to that from the
single best-fit parameterisation.
To confirm more detailed predictions of our model, we
also examined the specific distributions of heteroplasmy in
our new measurements. Given a mean heteroplasmy and an
organismal age, the parameterised BDP model predicts the
structure of the heteroplasmy distribution (see Methods and
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Predictions and experimental verification of the BDP model.
(A) New V′(h) measurements from the HB mouse system, with
optimised fits for the BDP, Wai (b) and Cao models. (B) Posterior
probabilities of each model given this data under decreasing ABC
threshold:  = {50, 40, 30, 25}. (C) All V′(h) measurements from the
HB model (points) with inferred V′(h) behaviour from ABC applied
to the BDP model (red curves). As in Fig. , this range does not
correspond to a credibility interval on individual measurements, but
rather on an expected underlying (population) variance, from which
individual variance measurements are sampled. The inferred behaviour
strongly overlaps with the inferred behaviour for the BALB/c system
(blue curves), suggesting that the BDP model applies to a genetically
diverse range of systems. (D) Heteroplasmy distributions. The trans-
formation h′ = − ln ∣∣(h−1 − 1)E(h)/(1− E(h))∣∣ [44] is used to compare
distributions with different mean heteroplasmy. Red jitter points are
samples from sets used to parameterise the BDP model; red curvesshow
the 95 % range on transformed heteroplasmy with time inferred from
these samples. Blue jitter points are samples withheld independent from
this parameterisation; their distributuions fall within the independently
inferred range. Insets show, in untransformed space, distributions of the
withheld heteroplasmy measurements (blue) compared to parameterised
predictions (red); no withheld datasets show significant support against
the predicted distribution (Anderson-Darling test, p < 0.05).6
next section). We parameterised the model using V′(h) val-
ues from a subset of half of the new measurements (chosen
by omitting every other sampled set when ordered by time).
Fig. D shows a comparison of measured heteroplasmy dis-
tributions with a 95 % bound from the parameterised BDP
model. We then tested the predictions of the parameterised
model against the other half of new measurements. 8 of the
test measurements (2.4%) fell outside the inferred 95% bound
from the training dataset, illustrating a good agreement with
distributional predictions. The Anderson-Darling test was
used to compare the distribution of heteroplasmy in sampled
oocytes with distributions predicted by our theory (given age
and mean heteroplasmy); no set of samples showed signifi-
cant (p < 0.05) departures from the hypothesis that the two
distributions were identical. Some example distributions are
presented in Fig. D (i), (ii), (iii).
The birth-death-partition model is analyti-
cally tractable
Importantly, the birth-death-partitioning model yields ana-
lytic solutions for the values of all genetic properties of in-
terest, using tools from stochastic processes (detail in Meth-
ods and Supplementary Information). These results facil-
itate straightforward further study and fast predictions of
timescales and probabilities of interest. The full theoreti-
cal approach is detailed in the Supplementary Information,
and equations for the mean and variance of mtDNA popu-
lations and heteroplasmy are given in the Methods. In Fig.
2A we illustrate that these analytic results exactly match the
numeric results of stochastic simulation, a result that holds
across all BDP model parameterisations. It is also straight-
forward to calculate the fixation probability P(m = 0), which
allows us to characterise all heteroplasmy distributions that
arise from the bottlenecking process, even when highly skewed
(see Methods and Supplementary Information). We have thus
obtained analytic solutions for the time behaviour of mtDNA
copy number and heteroplasmy throughout the bottleneck
with no assumptions of continuous population densities or
fixed population size, under a physical model with the most
statistical support given experimental data.
Mitochondrial turnover, degradation, and se-
lective pressures exert quantifiable influence
on heteroplasmy variance
We can use our theory to explore the dependence of bot-
tleneck dynamics on specific biological parameters. We first
explore the effects of modulating mtDNA turnover by varying
λ and ν in concert, corresponding to an increase in mtDNA
degradation balanced by a corresponding increase in mtDNA
replication. This increased mtDNA turnover increases the
heteroplasmy variance due to bottlenecking (see Fig. 4A).
This result arises due to the increased variability in mtDNA
copy number from the underlying random processes occur-
ring at increased rates. Additionally, we find that increasing
mtDNA degradation ν without increasing λ also increases
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Figure 4: Quantitative influences and clinical results from our
bottlenecking model. (A-C) Trajectories of copy number E(m) and
normalised heteroplasmy variance V′(h) resulting from perturbing dif-
ferent physical parameters. Trajectory C labels the ‘control’ trajectory
resulting from a fixed parameterisation; black dots show experimental
data; * denotes measurements from primary oocytes, modelled at 100
dpc. (A) Increasing (T+) and decreasing (T−) mtDNA turnover (both
mtDNA replication and degradation) by 20%. (B) Increasing (M+)
and decreasing (M−) mtDNA degradation throughout development by
a constant value (2 × 10−4, in units of day−1), while keeping replica-
tion constant. (C) Applying a positive (S+) and negative (S−) selective
pressure to mutant mtDNA by 5 × 10−6 day−1. (D) Probability of
crossing different heteroplasmy thresholds h∗ with time, starting with
initial heteroplasmy h0 = 0.3. (E) Probability distributions over embry-
onic heteroplasmy h0 given a measurement hm from preimplantation
sampling (** hm = 0.1; *** hm = 0.4) at different times.
heteroplasmy variance, in addition to decreasing the overall
mtDNA copy number (Fig. 4B). Applying this unbalanced in-
crease in mtDNA degradation without a matching change in
replication has a strong effect on mtDNA dynamics as it cor-
responds to a universal change in the ‘control’ applied to the
system, analogous, for example, to changing target copy num-
bers in manifestations of relaxed replication [21]. The simple
model we use does not include feedback and controls mtDNA
dynamics solely through kinetic parameters. Perturbing the
balance of these parameters thus strongly affects the expected
behaviour of the system. As we discuss later, elucidation
of the specific mechanisms by which control is manifest in
mtDNA populations will require further research, but these
numerical experiments attempt to represent the cases where a
perturbation is naturally compensated for (matched changes,
Fig. 4A) and where it is not (unbalanced change, Fig. 4B).
These results suggest that an artificial intervention increas-
ing mitochondrial degradation may generally be expected to
increase heteroplasmy variance during development. An in-
crease in mtDNA degradation is expected to either directly
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increase heteroplasmy variance (Fig. 4B) if mtDNA popu-
lations are weakly controlled, or to provoke a compensatory,
population-maintaining increase in mtDNA replication, thus
increasing mtDNA turnover, which also acts to increase vari-
ance (Fig. 4C) if mtDNA populations are subject to feedback
control. The increase in variance through either of these path-
ways will increase the power of cell-level selection to remove
cells with high heteroplasmy and thus purify the population.
For this reason, we speculate that mitochondrial degradation
may represent a potential clinical target to address the in-
heritance of mtDNA disease (more detail in Supplementary
Information).
Our model also allows us to explore the effect of differ-
ent mtDNA types experiencing different selective pressures,
by setting λ1 6= λ2 (mutant mtDNA experiences a prolifera-
tive advantage or disadvantage). Such a selective difference
causes changes in both mean heteroplasmy and heteroplasmy
variance, as shown in Fig. 4C (for example, if heteroplasmy
decreases towards zero, heteroplasmy variance will also de-
crease, as the wild type is increasingly likely to become fixed).
We do not focus further on selection in this study, noting that
selective pressures are likely to be specific to a given pair or
set of mtDNA types and are not generally characterised well
enough to perform satisfactory inference. However, we do
note that our theory gives a straightforward prediction for the
functional form of mean heteroplasmy when nonzero selection
is present, a sigmoid with slope set by the fitness difference
(see Methods).
Probabilities of exceeding threshold hetero-
plasmy values
A key feature of mtDNA diseases is that pathological symp-
toms usually manifest when heteroplasmy in a tissue exceeds a
certain threshold value, with few or no symptoms manifested
below this threshold [45]. The probability and timescale as-
sociated with which cellular heteroplasmy may be expected
to exceed a given value is thus a quantity of key interest in
clinical planning of mtDNA disease strategies.
In our model, the probability, as a function of time, of a
cell containing m1 wildtype and m2 mutant mtDNAs can be
straightforwardly derived. The resultant analytic expression
involves a hypergeometric function, also an important math-
ematical element in expressions describing mtDNA statistics
based on classical population genetics [23, 46]. The prob-
ability of obtaining a given heteroplasmy can therefore be
computed as a sum over all copy number states that cor-
respond to that heteroplasmy. However, as hypergeometric
functions are comparatively unintuitive and computationally
expensive, we here employ an approximation to the distri-
bution of heteroplasmy based upon the above moments that
are straightforwardly calculable from our model. This ap-
proximation involves fixation probabilities for each mtDNA
type and a truncated Normal distribution for intermediate
heteroplasmies (see Methods). In the Supplementary Infor-
mation we show that this approximation corresponds well to
the exact distributions calculated using the hypergeometric
function. We underline that exact heteroplasmy distributions
are straightfoward to compute using our approach: we use
the truncated Normal approximation as it represents the ex-
act distribution well, is more intuitively interpretable, and is
computationally very inexpensive.
Using this approach, the probability with time of a cell
exceeding a threshold heteroplasmy h∗ can be straightfor-
wardly computed for any initial heteroplasmy, allowing rigor-
ous quantitative elucidation of this important clinical quan-
tity (see Methods). Fig. 4D illustrates this computation
by showing the analytic probability with which thresholds
h∗ = 0.4, 0.5, 0.6 are exceeded at a time t, given the example
initial heteroplasmy h = 0.3. These results serve as a simple
example of the power of our modelling approach: any other
specific case can readily be addressed. Our theory thus al-
lows general quantitative calculation of the probability (and
timescale) that any given heteroplasmy threshold will be ex-
ceeded, given knowledge of the initial (or early) heteroplasmy.
Developmental sampling of embryonic het-
eroplasmy
We next turn to the question of estimating heteroplasmy lev-
els in a developed organism by sampling cells during devel-
opment. This principle, clinically termed preimplantation ge-
netic diagnosis [5, 47], assists in clinical planning by allowing
inference of the specific heteroplasmic nature of the embryo
itself rather than a population average of an affected mother’s
oocytes [48]. However, the complicated and stochastic nature
of the bottleneck makes this inference a challenging problem.
Given a heteroplasmy measurement from sampling hm, ac-
curate preimplantation diagnosis is contingent on knowledge
of the distribution P(h|hm), that is, the probability that the
embryonic heteroplasmy is h given that a measurement hm
has been made. We can use our modelling framework and
Bayes’ theorem (see Methods) to obtain a formula for this
conditional probability, allowing a rigorous probability to be
assigned to inferences from preimplantation sampling. Here,
as above, we employ the truncated Normal approximation for
the heteroplasmy distribution, noting that the exact treat-
ment using hypergeometric functions is straightforward but
more computationally expensive. Fig. 4E illustrates this pro-
cess by showing the probability distributions on embryonic
heteroplasmy when measurements hm = 0.1 or 0.4 have been
taken at different times during development. The increasing
heteroplasmy variance through development means that sub-
stantially greater uncertainty is associated with heteroplasmy
values inferred using measurements taken at later times. In
conclusion, although care must be taken in applying this rea-
soning to cell types in which, for example, mitochondrial and
cell turnover rates differ from those assumed here, or differen-
tiation leads to tissue-specific selective factors acting on the
mtDNA population, this formalism provides a general means
of rigorously inferring embryonic heteroplasmy through ge-
netic diagnosis sampling.
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Discussion
We have used a general stochastic model and approximate
Bayesian computation with the available experimental data
on developmental mtDNA dynamics to show that the bot-
tleneck is most likely manifest through stochastic mtDNA
dynamics and partitioning, with increased random turnover
later during development, a mechanism which we can de-
scribe exactly and analytically (Fig. 5). We emphasise
that the bottom-up construction of our model from physi-
cal first principles both increases the flexibility and general-
ity of our model, allowing different mechanisms to be com-
pared together, and providing information on mtDNA dy-
namics throughout development rather than estimating an
overall effect. We note that even though our model cannot
represent the full microscopic truth underlying the mtDNA
bottleneck, its ability to recapitulate the wide range of ex-
tant experimental measurements suggest that its study may
yield useful insights into the effects of different treatments
and perturbations on the bottleneck.
A key debate in the literature has focussed on the magni-
tude of the bottleneck. Some studies [11, 15] have observed
a depletion of mtDNA copy number during the bottleneck to
minima around several hundred; other studies [18, 19] have
observed that mtDNA copy number remains > 103. Our
study shows that observed increases in heteroplasmy variance
[16, 12] can be achieved across this range of potential minimal
mtDNA copy numbers, meaning that the much-debated mag-
nitude of mtDNA copy number reduction is not the sole crit-
ical feature of the bottleneck, in agreement with arguments
from Refs. [18, 19, 12]. We find that the role of stochastic
mtDNA dynamics can play a key role in determining het-
eroplasmy variance without additional mechanistic details, in
keeping with approaches proposed by Ref. [11]. The mecha-
nism with the most statistical support is thus consistent with
aspects from all existing proposals in the literature.
We have shown that, of the models proposed in the liter-
ature, a birth-death-partitioning model, proposed after Ref.
[11] and compatible with an interpretation of Ref. [12], is the
individually most likely mechanism, and capable of producing
experimentally observed heteroplasmy behaviour. We cannot,
given current experimental evidence, discount hybrid mech-
anisms, where birth-death-partitioning dominates the popu-
lation dynamics but small contributions from other mecha-
nisms provide perturbations to this behaviour, and propose
experiments to conclusively distinguish between these cases
(see Supplementary Information). As the expected statis-
tics of mtDNA populations undergoing inheritance of het-
eroplasmic mtDNA clusters is very similar to those under-
going binomial partitioning of mtDNAs (see Supplementary
Information), the inheritance of heteroplasmic nucleoids (as
opposed to individual mtDNAs) is not excluded by our find-
ings, though other recent experimental evidence suggests that
this situation may be unlikely [42, 41]. We contend that the
most likely situation may involve the partitioning of individ-
ual organelles, containing a mixture of homoplasmic nucleoids
of characteristic size < 2. Notably, this case (inheritance of
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Figure 5: Model for the mtDNA bottleneck. A summary of
our findings. (A) There is most statistical support for a bottlenecking
mechanism whereby mtDNA dynamics is stochastic within a cell cycle,
involving random replication and degradation of mtDNA, and mtDNAs
are binomially partitioned at cell divisions. (B) This mechanism results
in heteroplasmy variance increasing both due to stochastic partition-
ing at divisions and due to random turnover. The absolute magnitude
of the copy number bottleneck is not critical: a range of bottleneck
sizes can give rise to observed dynamics. Random turnover of mtDNA
increases heteroplasmy variance through folliculogenesis and germline
development.
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heteroplasmic groups, likely with fluid structure due to mix-
ing of organellar content and mitochondrial dynamics), gives
rise to statistics which our binomial model reproduces (see
Supplementary Information).
As mentioned in the model description, it is likely that
mitochondrial dynamics (fission and fusion of mitochondria)
[35] play a role in determining natural mtDNA turnover, and
particularly mtDNA turnover in the presence of pathologi-
cal mutations [49], through the mechanism of mitochondrial
quality control [32, 37]. Mitochondrial dynamics may also in-
fluence the elements of partitioning, through changes in the
connectivity of the mitochondrial network. In our current
model, these influences are coarse-grained into descriptions
of the dynamic rates of mtDNA replication and degradation,
and the characteristic elements that are partitioned at divi-
sions. These physical parameters, as opposed to the more
microscopic details of mitochondrial dynamics, are expected
to be the key determinants of heteroplasmy statistics through
development. Accounting for how these parameters, which
summarize the relevant outputs of mitochondrial dynamics,
connect to details of microscopic models of mitochondrial dy-
namics is an important future research direction to be ad-
dressed when more quantitative data is available.
The experimental data used to parameterise the first part of
our study was taken from four studies in mice. Observation of
similar dynamics in salmon [20] points towards the bottleneck
being a conserved mechanism in vertebrates. We also note
that our results in mice are broadly consistent with findings
from recent experiments in other organisms, suggesting that
in primates and humans, heteroplasmy variance may increase
at early developmental stages [50, 51], and that partitioning of
mitochondria is binomial in HeLa cells [52]. As more studies
become available on human mtDNA behaviour during devel-
opment we will test our model’s applicability and its clinical
predictions. We note that the results of a recent study of
human preimplantation sampling [48] found that earlier mea-
surements provided strong predictive power of mean hetero-
plasmy, about which substantial variation was recorded in the
offspring – both of which results are consistent with the ap-
plication of our model to theoretical sampling considerations.
In addition, recent observations that the m.3243A > G mu-
tation in humans both increases mtDNA copy number during
development [53], and displays a less pronounced increase of
heteroplasmy variance [51] than other mutations, are consis-
tent with the link between heteroplasmy variance and mtDNA
copy number in our theory.
The combination of modern stochastic and statistical treat-
ments that we have employed provides a generalisable and
powerful way to recapitulate experimental data and rigor-
ously deduce underlying biological mechanisms. We have
used this combination to explore pertinent questions regard-
ing the mtDNA bottleneck (and others have used a similar
philosophy to numerically explore mtDNA point mutations
[25]): we hope to convince the reader that such methodol-
ogy may be appropriate to explore other problems involving
stochastic biological systems. We have used new experimen-
tal measurements to confirm our theoretical findings, illus-
trating the beneficial and powerful coupling of mathematical
and experimental approaches to address competing hypothe-
ses in the literature. Our detailed elucidation of the bot-
tleneck allows us to propose further experimental methodol-
ogy to address the current unknowns in our theory, includ-
ing the specifics of mtDNA partitioning at cell division and
the roles of selective differences between mtDNA types; im-
portantly, we also propose a strategy to investigate our claim
that our most supported model is compatible with the subset-
replication picture of mtDNA dynamics. We list these exper-
iments in full in the Supplementary Information. Finally,
we believe that the theoretical foundation for mtDNA dy-
namics that we have produced allows increased quantitative
rigour in the predictions and strategies involved in mtDNA
disease therapies, illustrated by the above application of our
theory to problems in mtDNA sampling strategies, disease
onset timescales, and interventions to increase the power of
the bottleneck.
Methods
General model for mtDNA dynamics. Our ‘bottom-
up’ model represents individual mtDNAs as elements which
replicate and degrade either randomly or deterministically
according to the model parameterisation. Consonant with
experimental studies showing that it is often a single mutant
genotype that dominates the non-wildtype mtDNA popula-
tion of a cell [54], we consider two mtDNA types (wildtype
and mutant), though our model can readily be extended to
more mtDNA types. We denote the number of ‘wild-type’
mtDNAs in a cell as m1 and the number of ‘mutant’ mtD-
NAs as m2. The heteroplasmy of a cell is then h =
m2
m1+m2
,
that is, the population proportion of mutant mtDNA.
MtDNA dynamics within a cell cycle. Individual
mtDNAs are capable of replication and degradation, with
rates denoted λ and ν respectively. According to a binary
categorical parameter S, these events may be deterministic
(S = 0; the mtDNA population replicates and degrades by a
fixed amount per unit time) or Poisson processes (S = 1; each
individual mtDNA randomly replicates and degrades with av-
erage rates λ and ν). A parameter α controls the proportion
of mtDNAs capable of replication: α = 1 allows all mtDNAs
to replicate throughout development, α < 1 enforces a sub-
set proportion α of replicating mtDNAs a time cutoff T after
conception.
MtDNA dynamics at cell divisions. A parameter c
(cluster size; a non-negative integer) dictates the partitioning
of mtDNAs at cell divisions. When c = 0, partitioning is
deterministic, so each daughter cell receives exactly half of
its parent’s mtDNA. For c > 0, partitioning is stochastic.
When c = 1, partitioning is binomial: each mtDNA has a
50% chance of being inherited by either daughter cell. When
c > 1, the parent cell’s mtDNAs are grouped in clusters of size
c before division. Each cluster is then partitioned binomially,
with a 50% chance of being inherited by either daughter cell.
Different dynamic phases through development.
The mtDNA population changes in different ways as develop-
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ment progresses, first decreasing, then recovering, then slowly
growing. We include the possibility of different ‘phases’ of
mtDNA dynamics in our model to capture this behaviour.
Each phase j has its own associated pairs of λj , νj parameters
and may either be quiescent (involving no cell divisions) or
cycling (encompassing nj cell divisions). Thus, we may have
an initial cycling phase with low mtDNA replication rates, so
that copy number falls for several cell divisions, then a sub-
sequent ‘recovery’ cycling phase with higher replication rates
so that mtDNA levels are amplified, then quiescent phases
as cell lineages are identified. We allow six different phases,
with the first two fixed as cycling phases with the above dou-
bling times, and the final phase fixed to include no mtDNA
replication (representing the stable, final occyte state).
Initial conditions. The initial conditions of our model in-
volve an initial mtDNA copy number m0 (the total number of
mtDNAs in the fertilised oocyte) and an initial heteroplasmy
h0 (the fraction of these mtDNAs that are mutated).
Data acquisition. We used three datasets for mtDNA
copy number during mouse development: Cree [11]; Cao [18];
and Wai [12]. We use two datasets for heteroplasmy variance
during development: Wai [12] and Jenuth [16]. By conven-
tion, we use the normalised versions of heteroplasmy variance
(that is, measured variance divided by a factor h(1 − h)).
Where the measurements were not given explicitly in these
publications, we manually analysed the appropriate figures
to extract the numerical data. For these values, we used
data from correspondence regarding the Wai study (reply
to Ref. [17]), and manually normalise the Jenuth dataset.
The Jenuth dataset contains measurements taken in ‘mature
oocytes’ with no time given; we assume a time of 100 dpc for
these measurements, though this time is generalisable and
does not qualitatively affect our results. All values are pre-
sented in the Supplementary Information. Data on cell dou-
bling times in the mouse germ line is taken from Ref. [43],
suggesting that doubling times start with an interval of every
7h, then after around 8.5 days post conception (dpc) increase
to 16h, before the onset of a quiescent regime around 13.5
dpc (roughly consistent with the estimate of ∼ 25 divisions
between generations in the female mouse germ line [55]).
Simulation, model selection, and parametric infer-
ence. We use Gillespie algorithms, also known as stochastic
simulation algorithms [56], to explore the behaviour of our
model of the bottlenecking process for a given parameter-
isation. For a given model parameterisation, the Gillespie
algorithm is used to simulate an ensemble of 103 possible re-
alisations of the time evolution of mtDNA content, and the
statistics of this ensemble are recorded. The experimental
data we use is derived from sets of measurements of different
sizes; to compare simulation data with an experimental data-
point i corresponding to a statistic derived from ni measure-
ments, we sampled a random subset of ni of the 10
3 simulated
trajectories (all datapoints but one have n 103), and used
this subset to derive the simulated statistic for comparison to
datapoint i [29].
To fit the different models to experimental data we de-
fine a distance measure, a sum-of-squares residual between
the E(m) (in log space) and V(h) dynamics produced by our
model and observed in the data, weighted to facilitate com-
parison of these different quantities [29]. We also constrain
copy number to be < 5 × 105 at all points throughout de-
velopment, rejecting parameterisation that disobey this cri-
terion. Metropolis MCMC was used to identify the best-fit
parameterisation according to this distance function. For sta-
tistical inference, we use approximate Bayesian computation
(ABC), a statistical approach that has successfully been ap-
plied to parametric inference and model selection in dynam-
ical systems [30] to infer posterior probability distributions
both for individual models and the parameters of the models
given experimental data. ABC samples posterior probability
distributions on parameters that lead to behaviour within a
certain threshold distance of the given data; these posteriors
are shown to converge on the true posteriors as the threshold
value decreases to zero (see Supplementary Information). We
employed an MCMC sampler with randomly-selected initial
conditions. For further details, including priors, thresholds
and step sizes used in ABC, see Supplementary Information.
Minimum copy number was recorded directly from the result-
ing trajectories; our measure of total turnover σ is defined as
σ =
∑6
i=3 τ
′
iνi, the sum over quiescent dynamic phases of the
product of degradation rate and phase length.
Creation of heteroplasmic mice. Heteroplasmic mice
were obtained from a heteroplasmic mouse line (HB) we cre-
ated previously by ooplasmic transfer [44]. This mouse line
contains the nuclear DNA of the C57BL/6N mouse, and mtD-
NAs both of C57BL/6N and a wild-derived house mouse.
Both mtDNA variants belong to the same subspecies, Mus
musculus domesticus. For details on sequence divergence see
Ref. [44].
Isolation and lysis of oocytes. Mice were sacrificed at
the indicated ages by cervical dislocation. Ovaries were ex-
tracted and immediately placed in cryo-buffer containing 50%
PBS, 25% ethylene glycol and 25% DMSO (Sigma-Aldrich,
Austria) and stored at -80oC. For oocyte extraction, ovaries
were placed into a drop of cryo-buffer and disrupted using
scalpel and forceps. Oocytes were collected and remaining
cumulus cells were removed mechanically by repeated care-
ful suction through glass capillaries. Prepared oocytes were
then washed in PBS before they were individually placed into
compartments of 96-well PCR plates (Life Technologies, Aus-
tria) containing 10 µl of oocyte-lysis buffer [50] [50 mM Tris-
HCl, (p.H 8.5), 1 mM EDTA, 0.5% tween-20 (Sigma-Aldrich,
Austria) and 200 µg/mL ProteinaseK (Macherey-Nagel, Ger-
many)]. Samples covered stages from primary oocytes of 3
day-old mice up to mature oocytes of 40 day-old mice. Sam-
ples were lysed at 55oC for 2 h, and incubated at 95oC for
10 min to inactivate Proteinase K. The cellular DNA extract
was finally diluted in 190 µl Tris-EDTA buffer, pH 8.0 (Sigma-
Aldrich, Austria). 3µL were used per qPCR reaction.
Heteroplasmy quantification by Amplification Re-
fractory Mutation System (ARMS)-qPCR. Hetero-
plasmy quantification was performed by Amplification Re-
fractory Mutation System (ARMS)-qPCR, an established
method in the field [57, 58, 59], as described in Ref. [44].
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The study was conducted according to MIQE (minimum in-
formation for publication of quantitative real-time PCR ex-
periments) guidelines [44, 60]. The proportion between HB
derived and C57BL/6N mtDNA was determined by ARMS-
qPCR assays based on a SNP in mt-rnr2 [44]. These assays
were normalised to changes in the input mtDNA amount by
consensus assays, located in conserved regions of mt-Co2 and
mt-Co3 (see Supplementary Information). For the calculation
of mtDNA heteroplasmy, the assay detecting the minor allele
(C57BL/6N or wild-derived < 50%) was always used. If both
specific assays gave values > 50% (which can happen around
50% heteroplasmy), the mean value of both assays was taken.
All qPCR runs contained no template controls (NTCs) for all
assays; these were negative in 100%. Further experimental
details available in the Supplementary Information.
Analytic model. In the birth-death-partitioning model,
processes within a cell cycle constitute a birth-death process
which can be solved using generating functions [61]. For bino-
mial partitioning, the generating function for the system after
an arbitrary number of divisions has a recursive structure [62]
and an analytic solution can be obtained through solving a
Riccati recurrence relation. This reasoning also extends to
the different phases of replication and degradation, allowing
an exact generating function to be constructed for an arbi-
trary point in the bottleneck. Derivatives of this generating
function are then used to obtain moments of the distributions
of interest. The full procedure is given in the Supplementary
Information. Recall that we assume that the bottlenecking
process consists of a series of dynamic phases, which may
either involve cycling cells (and hence cell divisions) or qui-
escent cells. The expression for mean mtDNA copy number
E(m, t) at time t is:
E(m, t) = m0e(t−τ
∗)
∏
phases i
e(niτi+τ
′
i)(λi−νi)
2ni
, (2)
where ni is the number of cell divisions in phase i (0 for
quiescent phases), τi is the length of a cell cycle in cycling
phase i, τ ′i is the time spent in quiescent phase i (0 for cycling
phases), and τ∗ = Σi(niτi+τ ′i), so that t−τ∗ is the time since
the last cell division. E(m, t) is thus intuitively interpretable
as a product of the initial copy number with the effects of
halving at each cell division, and the copy number evolution
through past and current cell cycles and quiescent phases.
The expression for the variance is lengthier, taking the form
V(m, t) =
ΦE(m, t)∏
phases i 4
ni(e(λi−νi)τi − 2)2(λi − νi)2
+E(m, t)− E(m, t)2, (3)
where Φ is a lengthy, though algebraically simple, function
of all physical parameters, which we derive and present in the
Supplementary Information. Once the means and variances
associated with mutant and wild-type mtDNAs have been
determined (for brevity, we write these as µ1 ≡ E(m1, t), σ21 ≡
V(m1, t) and µ2 ≡ E(m2, t), σ22 ≡ V(m2, t)), the relations
below can be used to compute heteroplasmy statistics:
E(h) =
µ2
µ1 + µ2
≡ µh (4)
V(h) = µ2h
(
σ22
µ22
− 2σ
2
2
µ2(µ1 + µ2)
+
σ21 + σ
2
2
(µ1 + µ2)
2
)
(5)
Selection. The predicted mean heteroplasmy at time t as-
suming a constant selective pressure (though this assumption
can straightforwardly be relaxed) is given by Eqn. 4, which,
given Eqn. 2, straightforwardly reduces to
E(h) =
1
1 + 1−h0h0 e
−∆λt , (6)
where h0 is initial heteroplasmy and ∆λ is the increase
(or decrease, if negative) in replication rate of mutant over
wild-type mtDNA. Eqn. 6 predicts that mean heteroplasmy
in the presence of selection will follow a sigmoidal form (as
expected from population dynamics [63], by the constraint
that h0 must lie between 0 and 1, and by the intuitive fact
that heteroplasmy changes slow down as these limits are ap-
proached).
Threshold crossing. The probability of heteroplasmy ex-
ceeding a certain threshold h∗ is simply given by integrating
the probability distribution of heteroplasmy between h∗ and
1. The exact distribution of heteroplasmy can be written
as a sum over hypergeometric functions; however, for com-
putational efficiency and interpretability, we employ an ap-
proximation to this distribution involving the truncated Nor-
mal distribution and fixation probabilities. As shown in the
Supplementary Information, the distribution of heteroplasmy,
taking possible fixation into account, can be well approxi-
mated by
P(h) = (1− ζ1 − ζ2)N ′(h|µ, σ2) + ζ1δ(h) + ζ2δ(h− 1) (7)
where N ′ is the truncated Normal distribution (truncated
at 0 and 1), µ and σ2 are found numerically given our model
results for E(h) and V(h), and ζ1 ≡ P(h = 0) and ζ2 ≡ P(h =
1) are fixation probabilities, also straightforwardly calculable
from our model. The probability of threshold crossing for
0 < h∗ < 1 is then
P(h > h∗) = (1−ζ1−ζ2)
(
1− 1
2
(
1 + erf
(
(h∗ − E(h))/
√
2V(h)
)))
+ζ2.
(8)
Inference from heteroplasmy measurements. Given
a sampled measurement heteroplasmy hm, the probability
P(h0|hm) that embryonic heteroplasmy is h0 is given by
Bayes’ theorem P(h0|hm) = P(hm|h0)P(h0)/P(hm). Assum-
ing a uniform prior distribution on embryonic heteroplasmy
(though this can be straightforwardly generalised), we thus
obtain P(h0|hm) = P(hm|h0)/
∫ 1
0
P(hm|h′0)dh′0, and using the
above expression for the heteroplasmy,
P(h0|hm) = (1− ζ1 − ζ2)N
′(hm|µ, σ2) + ζ1δ(hm) + ζ2δ(hm − 1)∫ 1
0 dh
′
0(1− ζ1 − ζ2)N ′(hm|µ, σ2) + ζ1δ(hm) + ζ2δ(hm − 1)
,
(9)
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where µ, σ2, ζ1, ζ2 are functions of h0: µ, σ
2 may be found
numerically and the ζ values are analytically calculable (see
Supplementary Information).
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Time / dpc E(m) N Source study
0 2.5e5 22 Cree1
0.29 2.5e5 18 Cree1
0.58 5.8e4 9 Cree1
0.73 6.3e4 19 Cree1
0.88 4.8e4 33 Cree1
1.31 1.8e4 11 Cree1
7.5 4.5e2 596 Cree2
8.5 1.1e3 165 Cree2
10.5 1.6e3 96 Cree2
14.5 1.8e3 2615 Cree2,3
0 1.7e5 42 Cao1
0.29 7.1e4 32 Cao1
0.58 4.8e4 32 Cao1
0.88 2.1e4 32 Cao1
5.5 1.5e3 85 Cao2,3
6.5 1.6e3 43 Cao2,3
7.5 2.0e3 53 Cao2,3
7.75 2.0e3 42 Cao2,3
8.5 2.1e3 82 Cao2,3
9.5 2.2e3 93 Cao2,3
10.5 2.1e3 74 Cao2,3
11.5 2.0e3 67 Cao2,3
12.5 1.9e3 124 Cao2,3
13.5 2.1e3 71 Cao2,3
8.5 2.8e2 20 Wai4
9.5 2.5e3 20 Wai4
10.5 2.8e3 20 Wai4
12.5 4.0e3 20 Wai4
14.5 5.8e3 20 Wai4
16.5 2.4e3 20 Wai4
25 5.0e3 20 Wai4
29 1.0e4 20 Wai4
32 3.0e4 20 Wai4
46 6.5e4 20 Wai4
Time / dpc V′(h) N Source study
7.5 5.2e-6 12 Jenuth5
7.5 0.008 4 Jenuth5
7.5 0.004 3 Jenuth5
7.5 0.008 5 Jenuth5
23 0.039 40 Jenuth5
23 0.032 37 Jenuth5
23 0.040 35 Jenuth5
23 0.038 35 Jenuth5
23 0.037 34 Jenuth5
23 0.021 48 Jenuth5
23 0.026 45 Jenuth5
* 0.140 26 Jenuth5,6
* 0.017 24 Jenuth5,6
* 0.144 31 Jenuth5,6
* 0.021 49 Jenuth5,6
* 0.033 31 Jenuth5,6
8.5 0.016 20 Wai7,8
8.5 0.018 20 Wai7,8
9.5 0.018 20 Wai7,8
10.5 0.017 20 Wai7,8
10.5 0.025 20 Wai7,8
10.5 0.008 20 Wai7,8
12.5 0.017 20 Wai7,8
13.5 0.014 20 Wai7,8
13.5 0.015 20 Wai7,8
13.5 0.020 20 Wai7,8
13.5 0.021 20 Wai7,8
14.5 0.004 20 Wai7,8
16.5 0.015 20 Wai7,8
25.0 0.002 20 Wai7,8
25.0 0.002 20 Wai7,8
29.0 0.013 20 Wai7,8
29.0 0.027 20 Wai7,8
32.0 0.016 20 Wai7,8
32.0 0.023 20 Wai7,8
35.0 0.026 20 Wai7,8
35.0 0.029 20 Wai7,8
50.0 0.039 20 Wai7,8
51.1 0.043 20 Wai7,8
65.0 0.026 20 Wai7,8
Table 1: Source data used in this study. 1 Data referenced by number of cells post-conception is assigned a time measurement assuming the
7h → 16h doubling times from Ref. [43]. 2 Mean copy number taken directly from tabulated data. 3 (Weighted) average over germline cell classes
presented at this time point. 4 Extracted from data in figures; n not explicitly available so estimated as n = 20 from accompanying histograms
and discussion. 5 Manually normalised from given data. 6 Data from mature oocytes in next generation: time in dpc not available. 7 Extracted
from data in figures in correspondence following study. 8 n not explicitly available so estimated as n = 20 from accompanying histograms and
discussion in original paper.
Supplementary Information
1 Data from experimental studies
Table 1 contains the datapoints used in this study. These data are taken from Tables 1 and 2 of Ref. [11] (labelled ‘Cao’);
Tables 1 and 2 of Ref. [18]; Fig. 1 of Ref. [12] and Fig. 1 of the following correspondence (reply to Ref. [17]) (labelled
‘Wai’); and Table 2 of Ref. [16] (labelled ‘Jenuth’). Convention in the literature suggests that normalisation of measured
heteroplasmy variance values, performed by division by a factor h(1 − h), allows comparison of variance values from lines
with diverse absolute heteroplasmies: the Wai data from correspondence is already normalised, and we manually normalised
the Jenuth data using the h values present.
Where data in the original studies were presented as a function of number of cells in a developing organism, as opposed to
an explicit function of time, we have assigned times using the 7h→ 16h doubling times from Ref. [43]. Other sources assume
a 15h doubling time throughout early development: using the data interpreted in this way did not lead to a qualitative
difference in our conclusions and very little quantitative change in posterior distributions (data not shown). Some datapoints
did not have associated or readily available sample sizes N : for these datapoints we estimated N using available evidence in
the publication. To check for dependence on these values of N we performed our inference process with a range of alternative
N values and with a test case where N was set to 100 for every datapoint: all results and posteriors were qualitatively
similar, showing a lack of strong dependence of our conclusions on the specific numbers of samples involved in deriving the
experimental measurements (data not shown).
2 Heteroplasmic and homoplasmic clusters
The specific units of inheritance of mtDNA have been debated in the literature for decades. The smallest possible unit
of inheritance is a single mtDNA molecule; some studies have hypothesised that the unit of inheritance consists of groups
of mtDNA molecules. Within this picture, debate exists as to whether these groups are semi-permanent associations of
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molecules (which we will refer to as ‘quenched’ sets) or more fluid transient colocalisations of molecules (which we refer
to as ‘unquenched’). Furthermore, the size of these units is debated, with estimates ranging from an average size of 1.4
to 10 mtDNA molecules [39, 40], and it is unknown whether the mtDNAs within a group are strictly homoplasmic or if
heteroplasmic groups are possible, although current evidence, at the finest resolution, points towards homoplasmic groups
of size < 2 [42, 41, 64, 1].
We will classify these different pictures with three parameters. First, the characteristic size c of an mtDNA group. Second,
a classifier denoting whether these groups are quenched (in the sense that the individual constituents of a group remain the
same over many cell divisions) or unquenched (in the sense that the individual constituents of a group may change between
cell divisions). Third, a classifier denoting whether groups are necessarily homoplasmic, or if heteroplasmy is permitted.
An early hypothesis from Jacobs et al. [31] considered ‘nucleoids’ which correspond to quenched heteroplasmic groups
with c > 1, retaining their internal structure across cell divisions and containing different mtDNA types. If the mitochondrial
organelle is the unit of inheritance, we may expect unquenched heteroplasmic groups with c > 1, as mitochondrial dynamics
act to mix the content of the mitochondrial system between cell divisions, but organelles are likely to contain more than one
mtDNA molecule. If nucleoids are the units of inheritance and, as current understanding suggests, nucleoids are small and
homoplasmic (if mtDNA indeed exists in groups at all), the appropriate picture is c ' 1, homoplasmic groups.
Here we show that the heteroplasmy statistics resulting from these different pictures of grouped inheritance collapse onto
two representative cases: first, that corresponding to homoplasmic clusters with c > 1, and second, that corresponding to
c = 1 (binomial inheritance). Quenching – whether mtDNA content can remix within nucleoids – is shown to be unimportant
in determining heteroplasmy statistics. Our model for these different situations is as follows. We consider a cellular population
as consisting of a set of mtDNA molecules, existing in groups of size c. During a cell cycle, the population of groups doubles
deterministically (we ignore random birth-death dynamics in this model, in order to focus on partitioning dynamics), so that
every group produces one exact copy of itself. For unquenched simulations, a new set of groups is then formed by resampling
the individual mtDNA constituents of the cell. For quenched simulations (representing the situation postulated in Ref. [31]),
the existing groups remain intact. At cell divisions, groups are binomially partitioned between the two daughter cells.
The model is initialised with a cell containing m0 mtDNAs, split into (1 − h)m0 wild-type and hm0 mutant molecules.
These mtDNAs are clustered into m0/c groups, according to the cluster picture under consideration (i.e. homoplasmic or
heteroplasmic clusters). We simulate the subsequent doubling then partitioning of this system through cell divisions many
times, assuming a constant cell cycle length, and record the cell-to-cell heteroplasmy variance with time.
Fig. 6 shows the resultant heteroplasmy variance trajectories for different cases (with h0 = 0.1; other initial heteroplas-
mies showed similar behaviour). The first striking result is that the inheritance of heteroplasmic groups produces the same
heteroplasmy variance as binomial partitioning, regardless of cluster size. This behaviour is due to the balance between
stochasticity associated with the makeup of, and partitioning of, groups. A small number of large groups will experience
substantial partitioning noise, but larger heteroplasmic groups are more likely to faithfully represent the overall cell hetero-
plasmy. As identified in Ref. [31], the inheritance of heteroplasmic groups thus provides a means to facilitate local mtDNA
complementation while provoking no increase in heteroplasmy variance beyond that associated with binomial partitioning of
elements at divisions.
We also observe that quenched populations behave in the same way as unquenched populations. In the case of homoplasmic
groups, this result is obvious, as a set of homoplasmic nucleoids of a given size can only be constructed in one way for a given
number of mtDNA molecules of different types. For heteroplasmic groups, this result implies that resampling the cellular
population to produce a new group produces a negligible amount of additional stochasticity compared to that already present
in the random makeup and inheritance of groups. Thus, the only determinant factors of heteroplasmy variance related to
the inheritance of groups are whether groups are homoplasmic or heteroplasmic, and, if the former, the characteristic size of
groups.
These results illustrate that the binomial inheritance model can also describe the statistics associated with heteroplasmic
nucleoids of arbitrary size, over a timescale of several dozen cell divisions (suitable to describe the developmental process).
The theoretical long-term behaviour of these systems involves some more subtleties. At much longer times, the probability
that all mtDNA types become extinct in a cell is not negligible. When complete extinction cannot be ignored, heteroplasmy
statistics become poorly defined. This extinction timescale is shorter for cluster inheritance than for binomial inheritance, as
a greater variability in copy number (though not in heteroplasmy) results from each division for larger clusters. However, our
simulations indicate that as long as the heteroplasmy variance associated with heteroplasmic clusters remains well defined,
it matches that resulting from binomial inheritance.
We propose that a reasonable view may be that individual mitochondrial fragments, including several small, homoplasmic
nucleoids, are the likely elements of inheritance at partitioning. Furthermore, there is likely some movement of these nucleoids
within the mitochondrial network, and fission and fusion likely mean that a given mtDNA will not be associated with the
same static mitochondrial element in perpetuity. In this case, the picture of an unquenched, heteroplasmic group of mtDNAs
– those contained within a discrete element of the mitochondrial system – seems most reasonable. We can thus speculate
that, as demonstrated by the previous results, the precise size of mitochondrial fragments at partitioning is not important
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Figure 6: Heteroplasmy variance in a model system under several different group-inheritance regimes. V(h) over many cell divisions
when the elements of inheritance are heteroplasmic or homoplasmic groups of different size. Groups may be quenched (Q; constituents remain the
same across cell divisions) or unquenched (UQ; constituents are randomly resampled from the cellular population each cell cycle); for homoplasmic
clusters, an unquenched protocol yields identical results to the quenched protocol. V(h) behaviour differing from binomial partitioning (c = 1) is
only observed for homoplasmic groups with c ≥ 2. Points for heteroplasmic groups are slightly offset in the x-direction for clarity.
for the heteroplasmy dynamics (nor indeed is whether they are quenched or unquenched). Our simple binomial partitioning
model is thus consistent with what one might consider the most physiologically plausible model, and indeed with any models
not involving large and strictly homoplasmic groups as the elements of mitochondrial inheritance.
3 Parametric inference for bottlenecking dynamics
Our model is a function of the parameter set1 θ = {νi, λi, ni, τi, S, α, T, c, h0,m0, δλ}. For the following parameters we
use uninformative uniform priors on the given interval: λi, νi ∈ [0, 1]hr−1;S ∈ {0, 1};α ∈ [0.005, 1];T ∈ [0, 100]day; c ∈
[0, 100];h0 ∈ [0, 1];m0 ∈ [0, 106]. The following values are fixed from experimental studies [43, 55]: n1 = 29;n2 = 7; τ1 =
7hr; τ2 = 16hr. λ6 = 0hr
−1 is fixed to avoid mtDNA proliferation after development; h0 = 0.2 is fixed as an intermediate
value as heteroplasmy variance measurements are generally normalised; δλ, a parameter allowing a difference in replicative
rates between mutant and wildtype mtDNAs, is fixed at zero throughout as we ignore selective pressure. The parameter
τi for i > 2 is used to determine the length of time spent in different quiescent phases and is subject to the uniform prior
τi ∈ [0, 50]day.
Given these priors, we use an approximate Bayesian computation (ABC) approach to build a posterior distribution over
the parameters in our bottlenecking model [30]. ABC involves using a summary statistic ρ(θ,D) to compare the available
data D to the predictions of a model given parameters θ. If parameter sets are sampled from the set for which ρ ≤ ,
where  is a threshold difference between the resulting model behaviour and experimental data, the posterior distribution
P (θ|ρ(θ,D ≤ )) is sampled, which is argued to sufficiently approximate P (θ|D) for suitably small  [65].
We define a residual sum-of-squares difference between the results of a simulated model and experimental data [29]:
ρ(θ,D) =
Nm∑
i=0
(
logEθ(m|t = t(i)D,m)− logED(m|t = t(i)D,m)
)2
+
Nh∑
i=0
A1
(
Vθ(h|t = t(i)D,h)− VD(h|t(i)D,h)
)2
(10)
where D denotes experimental data. We thus amalgamate experimental results of two types: mean mtDNA copy number
(with Nm data points measuring ED(m) at times t(i)D,m), and mean and variance of heteroplasmy (with Nh data points
measuring VD(h) at times t(i)D,h). The sets of data for E(m) and V(h) contain different numbers of points and are of different
absolute magnitudes. We compensate for these differences by using the logarithms of copy number measurements (as these
values span several orders of magnitude), and weighting parameter A1 = 10
3. This weighting parameter compensates for
the different magnitudes and number of datapoints in each class of measurement, ensuring that the contribution to the total
residual from each set of data is of comparable magnitude. Our summary statistic thus records a residual sum-of-squares
1For reference, the meanings of these parameters are (as in Fig. 1D in the Main Text): replication (λi) and degradation (νi) rates; number
of cell divisions (ni) and cell cycle length (τi) in each dynamic phase i; deterministic or stochastic dynamics label (S = 0, 1 respectively); a
proportion α of mtDNAs capable of replication after threshold time T ; deterministic (c = 0), binomial (c = 1) or clustered (c > 1) partitioning
at divisions; initial heteroplasmy h0 and initial copy number m0; δλ is an additional parameter allowing a possible difference in replicative rates
between mutant and wildtype mtDNA: this is zero unless otherwise stated.
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Figure 7: Residual distributions at different ABC thresholds . The distribution of squared residuals corresponding to individual
experimental datapoints compared to an ensemble of simulated trajectories for (top) logE(m) (bottom) V(h). The V(h) residuals are scaled by
A1 = 103 to ensure that the two sets of measurements are compared on a quantitatively equal footing. As  is decreased (1,2,3,4 = 40, 50, 75, 100),
distributions of residuals from accepted trajectories tighten around zero.
difference between experiment and simulation values for logE(m) and V(h) at each time point where an experimental
measurement exists.
We performed our model selection process using several different alternative protocols, including comparing logarithms of
V(h) measurements (in contrast to the raw values) and varying A1 over orders of magnitude from 102 − 104 (corresponding
to unbalanced weighting, favouring E(m) and V(h) data respectively). In all cases, the BDP model identified in the Main
Text experienced substantially more support than any alternative. For inference involving the new dataset from the HB
model system, we use the default protocol above and set A1 = 3×103 to account for the threefold decrease in available V′(h)
datapoints.
We use an MCMC implementation of ABC, whereby we construct a Markov chain θi, where each state consists of a set of
trial parameters to be assessed. We create θi+1 by perturbing each parameter within θi with a perturbation kernel consisting
of a Normal distribution on each parameter with standard deviations between 0.1 − 1% of the width of the prior (varied
as the model depends more sensitively on some parameters than others). In the case of discrete parameter c, a continuous
representation c′ is used and varied in the MCMC approach, with c = b100c′c. We accept θi+1 as the new state of the chain
if ρ(θi+1,D) ≤ . We ran 106 MCMC iterations for ABC model selections and checked convergence by running five instances
of each simulation for different random number seeds.
For the initial optimisation of model fitting, we ran 106 MCMC steps using the protocol above but accepting a move
according to the Metropolis-Hastings protocol [66], recording the parameterisation leading to the lowest recorded residual.
In this case we used uninformative initial conditions, with identical choices for all rate parameters, corresponding to an
inaccurate trajectory of copy number and heteroplasmy variance. For model selection, we used the protocol above, with a
different set of parameters θM for each model M , with each MCMC step proposing a random model from the Cao alone, Wai
alone, and BDP set described in the text, as in the SMC ABC model selection protocol proposed in Ref. [30]. We record
the proportion of accepted steps involving each model type. The parameterisations found through initial optimisation were
used as initial conditions in the ABC model selection and inference simulations.
Initial optimisation identified parameterisations all displaying residuals under  = 50. We chose  = {45, 50, 60, 75} for
the ABC model selection simulations to display the varying degrees of support for each model as stricter agreement with
experiment was enforced. We chose  = 40 for the ABC inference of BDP model parameterisation to ensure these models all
displayed better fits to data than the alternative models. In Fig. 7 we illustrate the distribution of squared residuals for the
BDP model under a range of  values.
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4 Posteriors for all variables and datasets
In Fig. 8 we display all posterior distributions for all parameters resulting from our ABC approach assuming the BDP
model. There is substantial variability in the possible timescales and magnitudes of random turnover associated with each
random dynamic phase i > 2, exemplified by the complicated and bimodal structure of the posteriors on these parameters.
This variability reflects the fact that an increase in heteroplasmy variance can be achieved through a variety of specific
mtDNA trajectories, and current experimental data is insufficient to distinguish specific time behaviours within this variety.
However, the total contribution of each random phase to the overall dynamics is more constrained, as shown in the posterior
distribution on a measure of total random turnover σ =
∑6
i=3 τ
′
iνi. This quantity is the sum over all later phases of the
product of the length of that phase and the rate of random turnover, thus giving a measure of total random turnover. The
fact that this posterior is more tightly constrained than the posteriors on individual ti, νi parameters suggests that the
required mtDNA turnover can be achieved through a range of specific dynamic trajectories from the inferred mechanism:
for example, the exact time at which random mtDNA turnover sharply increases is currently flexible (though constrained to
lie around 25 dpc) without more detailed data. This flexibility is also observed in the trajectories of posterior distributions
in the main text.
5 Experimental measurements
Table 2 contains the measurements of heteroplasmy h, mean heteroplasmy E(h), raw and normalised heteroplasmy variance
V(h) and V′(h), and number of datapoints n, from the HB model system. Experimental procedures are described in Methods;
further specifics follow.
Consensus assays:
Co2-f:GCCAATAGAACTTCCAATCCGTATAT,
Co2-r:TGGTCGGTTTGATGTTACTGTTG,
Co2-FAM:CTGATGCCATCCCAGGCCGACTAA-BHQ1 (Amplicon length: 136bp);
Co3-f:TCTTATATGGCCTACCCATTCCAA,
Co3-r:GGAAAACAATTATTAGTGTGTGATCATG,
Co3-FAM: TTGGTCTACAAGACGCCACATCCCCT-BHQ1 (Amplicon length: 103bp).
ARMS-assays:
16SrRNA2340(3)G-f: AATCAACATATCTTATTGACCaAG (haplotype C57BL/6N),
16SrRNA2340(3)A-f: AATCAACATATCTTATTGACCgAA (haplotype HB);
16SrRNA2458-r: CAC CAT TGG GAT GTC CTG ATC,
16SrRNA-FAM: FAM-CAA TTA GGG TTT ACG ACC TCG ATG TT-BHQ-1. (Amplicon length: 142bp).
Every qPCR run consisted of one consensus and an ARMS assay.
Master-mixes for triplicate qPCR reactions contained 1x buffer B (Solis BioDyne, Estonia); 4.5 MgCl2 for the ARMS and
the Co3 consensus assays, and 3.5 mM MgCl2 for the Co2 consensus assay; 200 M of each of the four deoxynucleotides (dNTPs,
Solis BioDyne, Estonia), HOT FIREPol DNA polymerase according to the manufacturers instructions (Solis BioDyne,
Estonia), 300 nM of each primer and 100 nM hydroloysis probe (Sigma-Aldrich, Austria). Per reaction 12 µL of master-mix
and 3 µL DNA were transferred in triplicates to 384-well PCR plates (Life Technologies, Austria) using the automated
pipetting system epMotion 5075TMX (Eppendorf, Germany). Amplification was performed on the ViiA 7 Real-Time PCR
System using the ViiATM 7 Software v1.1 (Life Technologies, USA). DNA denaturation and enzyme activation were performed
for 15 min at 95oC. DNA was amplified over 40 cycles consisting of 95oC for 20 sec, 58oC for 20 sec and 72 oC for 40 sec for
both assays.
The standard curve method was applied. Amplification efficiencies were determined for each run separately by DNA
dilution series consisting of DNA from wild-derived mice, harbouring the respective analysed mtDNA. Typical results: slope
= -3.665, -3.562, -3.461, -3.576; mean efficiency = 0.87, 0.9, 0.94, 0.90; and Y-intercept = 32.2, 28.3, 33.8, 34.5; for the
consensus Co2, consensus Co3, C57BL/6N and HB assays respectively. Coefficient of correlation was > 0.99 in all assays
in all runs. All target samples lay within the linear interval of the standard curves. To test for specificity, in each run a
negative control sample, i.e. a DNA sample of a mouse harbouring the mtDNA of the non-analysed type in the heteroplasmic
mouse (i.e. C57BL/6N or HB mtDNA) was measured. All assays could discriminate between C57BL/6N and HB mtDNA
at a minimum level of 0.2%. Target sample DNA was tested for inhibition by dilution in Tris-EDTA buffer (Sigma-Aldrich,
Austria), pH 8.0.
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Figure 8: Posterior distributions on model parameters. The posterior distributions on individual model parameters, assuming the inferred
BDP bottlenecking mechanism. Replication rates are presented as κ = λ − ν, thus representing overall proliferation rates of mtDNA. Units are
omitted for clarity. Pale, single-values distributions correspond to parameter values fixed within the model (κ6 = 0 to prevent mtDNA proliferation
after development; τ1 = 7hr, τ2 = 16hr fixed by data on cell doubling times; h0 = 0.2 fixed for simplicity as heteroplasmy variances are normalised;
δλ = 0 fixed to avoid varying selective pressure). The ‘turnover’ parameter, described in the text, is
∑6
i=3 τ
′
iνi, a measure of the total random
turnover in the mtDNA population.
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Age 3 3 4 4 4 4 8 8 9 9 9 24 37 37 40
n 25 30 21 13 13 11 30 34 20 17 36 25 24 20 20
E(h) 0.501 0.419 0.183 0.337 0.382 0.354 0.301 0.559 0.193 0.245 0.049 0.457 0.566 0.276 0.238
V(h) 0.00256 0.00359 0.00824 0.01308 0.00913 0.00461 0.00350 0.00631 0.00408 0.00301 0.00097 0.00625 0.01000 0.00913 0.00662
V′(h) 0.0102 0.0147 0.0551 0.0585 0.0387 0.0202 0.0167 0.0256 0.0262 0.0163 0.0210 0.0252 0.0407 0.0457 0.0364
h× 100 40.8 26.5 7.4 16.7 26.9 25.1 18.2 38.7 8.3 13.3 1.7 32.5 38.0 12.8 8.9
43.4 30.6 7.6 23.1 28.8 25.7 22.0 41.7 9.3 16.9 1.7 32.6 39.2 13.8 12.1
44.1 31.8 7.9 24.0 29.4 29.1 23.7 43.9 10.8 20.1 1.8 37.1 45.9 15.9 13.9
44.2 33.2 9.6 24.4 29.8 30.8 23.9 46.4 13.5 20.2 1.9 37.1 50.9 16.6 15.7
46.6 36.4 9.7 26.8 30.2 36.5 24.6 47.5 13.5 20.2 2.0 38.0 51.0 20.3 18.8
46.7 37.7 10.3 27.0 36.7 36.7 25.9 47.9 15.8 21.3 2.8 39.5 51.7 20.6 19.1
46.9 37.9 12.4 28.6 37.1 38.2 26.0 49.5 16.3 23.7 2.8 40.0 51.7 21.8 19.5
47.4 38.7 14.3 39.8 40.2 38.3 26.2 51.4 16.4 24.9 2.9 41.1 51.8 23.6 20.8
48.0 39.2 14.8 40.4 40.5 40.4 26.3 51.5 18.4 25.2 2.9 43.0 52.0 23.8 22.5
48.4 39.5 16.0 41.9 43.6 43.6 26.9 52.8 18.7 26.2 3.0 43.7 54.1 26.2 22.7
48.5 39.7 17.0 42.9 45.8 44.8 26.9 52.8 20.7 27.0 3.0 43.7 54.2 28.3 23.2
48.7 41.4 17.1 50.1 46.7 27.8 52.9 20.7 27.3 3.0 44.2 54.4 29.6 23.4
49.3 42.1 18.6 52.8 60.5 28.9 53.2 21.3 27.6 3.0 44.5 54.9 32.6 27.8
50.3 42.6 19.7 29.1 53.2 21.8 27.8 3.3 46.3 55.3 33.1 28.9
50.5 42.7 20.8 29.7 53.5 23.8 28.2 3.3 46.6 55.7 33.1 29.4
50.6 42.7 25.7 29.9 53.9 24.2 30.0 3.5 47.0 57.2 34.5 30.1
50.8 42.9 25.7 30.1 54.2 26.5 36.7 3.5 49.1 57.5 38.4 30.9
51.2 43.8 26.4 30.7 55.2 26.5 3.7 49.8 59.9 40.5 34.8
53.7 44.5 28.3 31.3 56.0 26.8 3.8 50.1 61.1 42.2 35.2
54.5 44.7 35.6 31.7 56.2 32.1 3.8 51.8 64.8 43.9 39.4
55.0 44.8 39.3 32.6 57.1 4.0 53.0 69.9
56.2 45.9 33.0 57.3 4.0 54.3 74.1
56.6 47.0 33.4 59.8 4.9 55.7 76.1
59.0 47.6 33.6 60.0 5.5 55.7 76.5
62.0 48.7 34.7 60.1 5.8 66.2
48.7 34.9 61.3 5.9
48.8 35.3 61.3 6.0
48.9 35.8 62.1 6.1
49.1 41.2 65.6 6.7
49.7 48.5 67.1 7.9
68.3 8.2
69.2 8.3
69.4 8.5
70.1 8.8
11.6
16.6
Table 2: New heteroplasmy measurements from the HB model system. Heteroplasmy measurements and statistics from the HB model
system. Ages are given in days after birth.
6 Bottlenecking mechanisms and further experimental elucidation
Here we summarise potential mechanisms for the bottleneck that conflict with our statistical interpretation, highlighting the
reasons for the conflict. We also propose further experiments that would efficiently provide more evidence to distinguish
these hypotheses.
6.1 Other proposed mechanisms
Random partitioning of homoplasmic mtDNA clusters. Ref. [18] suggests a less powerful depletion of mtDNA
copy number during early development than assumed by other studies, with heteroplasmy variance increase instead being
explained by the partitioning of clusters of mtDNA at cell divisions. However, the time period over which Refs. [12] and [16]
observe increasing heteroplasmy variance corresponds to a situation in which germ line cells are largely quiescent, immediately
suggesting that partitioning at cell divisions cannot explain increasing variance (as cell divisions do not occur). Furthermore,
results from our model suggest that, unless these clusters are very small, this mechanism would immediately lead to a rather
higher and sharper increase in heteroplasmy variance than observed.
Replication of a specific subset of mtDNAs during folliculogenesis. Ref. [12] proposes a mechanism in which only
a subset of mtDNAs replicate during folliculogenesis. There are several specific dynamic schemes by which this mechanism
could be manifest. The first that we consider involves the following scenario: at some point during development, around the
start of folliculogenesis, a specific subset of mtDNAs in each cell is ‘marked’ as able to replicate (we next consider the case
in which this subset is more plastic with time). In this case, the effect of ‘switching off’ replication of a subset of mtDNAs
depends on the balance of replication and degradation rates of the mtDNA population:
• Low replication, low degradation. In this case, the population stays largely static; the switching off of replication has
little effect, and the heteroplasmy variance cannot increase to the levels observed in experiment.
• Low replication, high degradation. In this case, the high degradation rate ensures that the non-replicating mtDNAs are
removed from the cell, providing a ‘bottleneck’ as only the replicating mtDNAs remain. However, this regime yields a
transient period of mtDNA copy number depletion, while the non-replicating mtDNAs are degrading but the (small)
population of replicating agents remains low. This copy number depletion is not observed.
• High replication, high degradation. In this case, non-replicating mtDNAs are removed and replicating mtDNAs are
capable of fast enough replication to survive the transient drop in copy number. However, the rates associated with this
mechanism are necessarily high enough such that the increase in heteroplasmy variance is very sharp, notably more so
than the smooth increase with time observed in experiment (see, for example, Fig. 2A in the Main Text).
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• Combined subset replication, and/or heteroplasmic cluster inheritance, with and random dynamics. Our
approach does not provide support against a model combining our inferred mechanism (increased random turnover of
mtDNAs) with some other dynamic schemes, namely (a) that in which only a subset of mtDNAs may replicate during
folliculogenesis, and/or (b) where heteroplasmic mtDNA clusters, rather than individual mtDNAs, are the units of
inheritance. A combination with (a) would allow the reduction of the key parameters associated with each: so the
rate of random turnover could be lower, and the proportion of replicating genomes larger, than in the case of the pure
incarnations of those respective mechanisms. This scheme may thus provide a viable alternative – however, it requires an
introduction of two coupled mechanisms, which experimental data currently cannot disambiguate. For this reason and for
parsimony, we report the case where random dynamics alone are responsible, and below suggest experimental protocols
to further elucidate this possible link or its absence. A combination with (b) is possible and cannot be discounted using
the available data, as the trajectories of heteroplasmy variance under (b) and under binomial inheritance are the same.
We propose observations of mitochondrial ultrastructure and mtDNA localisation during development to resolve this
remaining mechanistic question.
6.2 Observation of a subset of replicating genomes
Ref. [12] performs BrU labelling to observe the proportion of mitochondria replicating in primary oocytes between P1-4
(21-25 dpc on our time axis). The observations contained therein (Fig. 2 in Ref. [12]) show a small subset of BrU-labelled
mitochondrial foci compared to the overall population of mitochondria labelled with another dye. Here we show that this
observation is compatible with (and expected from) our proposed model of random mtDNA turnover.
Consider a population of mtDNAs replicating with rate λ and degrading with rate ν. We model the BrU labelling assay
as follows. At time t = 0, we begin the BrU labelling, which we conservatively model as a perfect process, so that every
mtDNA that replicates becomes labelled. We continue this labelling until t = t∗, when we observe the proportion of labelled
mtDNAs.
For simplicity, we will consider a fixed population of mtDNAs of size N , though this reasoning extends to changing
population size. We denote by l the number of labelled mtDNAs. After BrU exposure, this number may change in three
ways: (A) a replication event involving a previously unlabelled mtDNA will produce two new labelled mtDNAs; (B) a
replication event involving a previously labelled mtDNA will produce one new labelled mtDNA; (C) a degradation event
involving a labelled mtDNA will remove one labelled mtDNA. The dynamics of labelled mtDNA number during BrU exposure
are given by
dl
dt
= (A) + (B) + (C) (11)
= 2λ(N − l) + λl − νl (12)
Assuming that l = 0 at t = 0, the solution of this equation, for the number of labelled mtDNAs at time t∗, is
l =
2Nλ
λ+ ν
(
1− e−(λ+ν)t∗
)
(13)
Assuming a constant population size requires λ = ν. The conclusions of this illustrative study do not substantially change
if we allow (λ 6= ν) and hence an increasing or decreasing population. We consider the values of λ and ν required to yield
values of l comparable with those found in Ref. [12]. We will roughly estimate these values, based on the proportion of
labelled foci observable, as l = 0.5N for 24h BrU exposure (half of observed mtDNAs being labelled) and l = 0.05N for 2h
BrU exposure (5% of observed mtDNAs being labelled). A value of λ = ν = 0.014 hr−1 yields l = 0.49N at t∗ = 24hr and
l = 0.055N at t∗ = 2hr.
Fig. 3D in our Main Text gives the posterior distribution on ν, characterising the rate of random mtDNA turnover in our
model, at different times. It can be seen that a value of ν = 0.35 day−1 comfortably falls within the region of high posterior
density during the time range 21-25 d.p.c – lying immediately before the strong increase in random turnover that our model
subsequently predicts. Our inferred mechanism of random mtDNA turnover is thus compatible with the observations of a
labelled subset of mtDNAs in the BrU incorporation assay in Ref. [12] – we would expect to see roughly the observed labelling
proportion simply due to the likely rates of random mtDNA turnover inferred at that stage of development. Furthermore,
we can use this line of reasoning to produce a testable prediction: similar experiments carried out several days later – when
random mtDNA turnover is inferred to increase substantially – should show a larger subset of labelled mtDNAs for the same
BrU exposure.
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Measurement Purpose
MtDNA copy number before and after cell divisions and/or
variance of copy number between daughter cells
To elucidate mechanism of mtDNA partitioning and
whether this partitioning is deterministic or stochastic.
Copy number trajectories with different mtDNA hetero-
plasmies
To assess the modulation of copy number dynamics by
mtDNA heteroplasmy via retrograde signalling.
Measurement of mean heteroplasmy through development,
with a variety of mtDNA type pairings
To assess and quantify to what extent selection modulates
mtDNA dynamics during germline development
Copy number measurements after upregulation of mi-
tophagy
To assess the presence and strength of compensatory mech-
anisms that may act to preserve mtDNA copy number –
and hence whether upregulating mitophagy will act to in-
crease mtDNA turnover or simply lower copy number.
Heteroplasmy variance after upregulation of mitophagy To assess the efficacy of mitophagy for increasing the power
of the bottleneck.
Heteroplasmy distribution in cells after the bottleneck from
sampled/known initial heteroplasmy
To confirm predictions for threshold crossing and statistics
between generations.
BrU incorporation in oocytes between 30 and 40 dpc To confirm the random turnover mechanism: we expect a
large proportion of BrU incorporation subset of mtDNAs
to be observed in this time period (see Section 6.2).
Mitochondrial ultrastructure and mtDNA localisation dur-
ing development
To assess and characterise any potential modulation of the
size of units of mitochondrial inheritance by mitochondrial
dynamics through development, in particular, investigating
whether there is time-varying modulation of cluster size at
points of division.
Table 3: Experiments for further elucidation of the mtDNA bottleneck.
6.3 Experimental elucidation
In Table 3 we list several classes of potential experimental protocols that would assist in further elucidation of the bottle-
necking mechanism and our predictions. Potentially useful results include further characterisation of the microscopic detail
underlying mtDNA dynamics during development, confirmation of our random turnover model, assessing degree to which
heteroplasmy modulates copy number dynamics and exploring our predictions relating mitophagy and bottlenecking power.
7 Mitophagy regulation
The results from our model suggest a potential clinical pathway for increasing heteroplasmy variance, and thus the power of
the bottleneck to remove heteroplasmic cells. We have shown that upregulation of mtDNA degradation (for example, through
increasing mitophagy) leads to lower mtDNA copy numbers and greater heteroplasmy variance. It is unclear whether a given
treatment will have the sole effect of upregulating mitophagy: it seems likely that compensatory mechanisms (which we do
not explicitly model, but may include retrograde signalling [67]) will engage to stabilise mtDNA copy number. However,
such mechanisms would most straightforwardly be expected to act through increasing mtDNA proliferation, thus having the
net effect of increasing mtDNA turnover. We have shown that such an increase in turnover also increases the heteroplasmy
variance in a population. We therefore propose that upregulating mitophagy may be a fruitful pathway of investigation for
increasing bottlenecking power, either as a standalone effect or due to the action of compensatory mechanisms it may invoke.
Speculatively, potential strategies to upregulate mitophagy may include the limited use of uncouplers to accelerate the
mitophagy normally involved in quality control [68]; targetted chemical treatments with agents that have been identified as
regulating mitophagy, including glutathione in yeast [69] and C18-pyridium ceramide in human cancer cells [70]; modulation
of mitochondrial ultrastructure and dynamics to upregulate fission, intrinsically linked to the process of mitophagy [37, 71];
or the use of existing drugs which have been found to modulate mitophagy, such as Efavirenz [72].
8 Heteroplasmy statistics
We have defined heteroplasmy by
h =
M2
M1 +M2
. (14)
To find statistics for this quantity we consider the Taylor expansion of a function f(X1, X2) of two random variables
X1, X2 about a point (µ1, µ2), where µi = E(Xi). We assume that the moments of Xi are well-defined and both have zero
probability mass at Xi = 0. The Taylor expansion is:
f(X1, X2) = f(µ1, µ2) + f1(µ1, µ2)(X1 − µ1) + f2(µ1, µ2)(X2 − µ2) + higher order terms, (15)
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where fi denotes the derivative of f with respect to Xi. We truncate the expansion at first order for later algebraic
simplicity, noting that even with this level of precision, the agreement between the resulting analysis and numerical simulation
is excellent. Then
E(f(X1, X2)) = E(f(µ1, µ2) + f1(µ1, µ2)(X1 − µ1) + f2(µ1, µ2)(X2 − µ2) + ...). (16)
We note that E(Xi − µi) = 0, so
E(f(X1, X2)) ' f(µ1, µ2). (17)
Similarly,
V(f(X1, X2)) = E((f(X1, X2)− E(f(X1, X2)))2) (18)
' E((f(X1, X2)− f(µ1, µ2))2) (19)
= E((f1(µ1, µ2)(X1 − µ1) + f2(µ1, µ2)(X2 − µ2))2), (20)
and noting that E((Xi − µi)2) = V(Xi) we obtain
V(f(X1, X2)) ' (f1(µ1, µ2))2V(X1) + (f2(µ1, µ2))2V(X2) + 2f1(µi, µ2)f2(µ1, µ2)C(X1, X2), (21)
where C(X1, X2) is the covariance of X1 and X2. If we now use f(X1, X2) = X1X2 , we have f1 = X
−1
2 , f2 = −X1X−22 ; so
E(X1/X2) ' E(X1)/E(X2) (22)
V(X1/X2) ' V(X1)/E(X2)2 + E(X1)2V(X2)/E(X2)4 − 2E(X1)C(X1, X2)/E(X2)3. (23)
If X1 = M2 and X2 = M1 + M2, and M1 and M2 are independent (due to the lack of coupling between the mtDNA
species), C(X1, X2) = V(M2), and so
E(h) =
E(M2)
E(M1) + E(M2)
(24)
V(h) =
(
E(M2)
E(M1) + E(M2)
)2
×
(
V(M2)
E(M2)2
− 2V(M2)
E(M2)(E(M1) + E(M2))
+
V(M1) + V(M2)
(E(M1) + E(M2))2
)
, (25)
9 Derivation of analytic results for binomial model
Generating function within a cell cycle. To make analytic progress describing the mitochondrial content of quiescent
cells, and within a single cell cycle of dividing cells, we use a birth and death model to describe mitochondrial evolution.
Without cell divisions, the dynamics of a population of replicating and degrading entities is given by the master equation
dP (m, t)
dt
= ν(m+ 1)P (m+ 1, t) + λ(m− 1)P (m− 1, t)− (ν + λ)mP (m, t), (26)
P (m, 0) = δmm0 , (27)
with P (m) the probability of observing the system with a copy number m at time t, and m0 the initial copy number. The
corresponding generating function, using the transformation G(z, t) =
∑
m z
mP (m, t), obeys
∂G(z, t)
dt
= (ν(1− z) + λ(z2 − z))∂G(z, t)
∂z
(28)
G(z, 0) = zm0 , (29)
which is straightforwardly solved by
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G0(z, t|m0) =
(
(z − 1)νe(λ−ν)t − λz + ν
(z − 1)λe(λ−ν)t − λz + ν
)m0
(30)
≡ [g(z, t)]m0 , (31)
where the 0 subscript signifies that no divisions have occurred, and we have specifically labelled the base of G0 as g0 for
later convenience.
Generating function over cell divisions. We now consider a system undergoing cell divisions. Now, we have a
population of organelles with time evolution described by a generating functionG = [g]
m0 and subject to binomial partitioning
at cell division. The probability distribution of m after a single cell division is:
P1(m, t|m0) =
∞∑
m1,b=0
m1,b∑
m1,a=0
P0(m, t|m1,a)
(
m1,b
m1,a
)
2−m1,bP0(m1,b, τ |m0), (32)
where mi,a,mi,b mean respectively the number of individuals after and before the ith cell division, and the subscript in P0
denotes the fact that this function refers to time evolution within a cell cycle (with no division). The sum takes into account
all possible configurations of the system up to the cell division then all possible configurations afterwards, with weighting
according to a binomial partitioning. This line of reasoning can straightforwardly be extended to n cell divisions [62]:
Pn(m, t|m0) =
∞∑
mn,b=0
mn,b∑
mn,a=0
...
∞∑
m1,b=0
m1,b∑
m1,a=0
P0(m, t|mn,a)
n−1∏
i=1
Φi, (33)
where Φi is a ‘probability propagator’ of the form
Φi =
(
mi,b
mi,a
)
2−mi,bP0(mi,b, τ |mi+1,a), (34)
and mn+1,a ≡ m0. For clarity, we introduce the nomenclature:
′∑
i,j
≡
∞∑
mi,b=0
mi,b∑
mi,a=0
...
∞∑
mj,b=0
mj,b∑
mj,a=0
(35)
Now consider the generating function of Pn:
Gn(z, t|m0) =
∑
m
zmPn(m, t|m0) (36)
=
∑
m
′∑
n,1
zmP0(m, t|mn,a)
n−1∏
i=1
Φi (37)
=
′∑
n,1
G0(z, t|mn,a)
n−1∏
i=1
Φi (38)
=
′∑
n−1,1
∞∑
mn,b=0
mn,b∑
mn,a=0
[g0(z, t)]
mn,a
(
mn,b
mn,a
)
2−mn,b
︸ ︷︷ ︸
binomial term
P0(mn,b, τ |mn−1,a)
n−2∏
i=1
Φi (39)
=
′∑
n−1,1
∞∑
mn,b=0
︷ ︸︸ ︷(
1
2
+
g0(z, t)
2
)mn,b
P0(mn,b, τ |mn−1,a)︸ ︷︷ ︸
generating function with transformed variable
n−1∏
i=1
Φi (40)
≡
′∑
n−1,1
︷ ︸︸ ︷
G0(z
′, τ |mn−1,a)
n−2∏
i=1
Φi, (41)
where we have used the identity
∑b
a=0 x
a
(
b
a
)
2−b ≡ ( 12 + x2 )b and changed variables z′ = 12 + g0(z,t)2 . Comparing Eqns. 38
and 41 and following this process by induction we can see that the overall generating function is Gn = h
m0
0 , where h is the
solution to the recursive system
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hi = g0
(
1
2
+
hi+1
2
, τ
)
(42)
hn = g0(z, t). (43)
hi is of the form
ahi+1+b
chi+1+d
(from Eqn. 30). This expression takes the form of a Riccati difference equation and can be
solved exactly after Ref. [73]. The solution is straightforward but algebraically lengthy, and we defer presentation of the full
procedure to a future technical publication. The overall solution is:
GC(z, t, n) = h0 =
2n(l − 2)(λz − ν) + l′(z − 1)((λ(2n − ln)− νln(l − 2)))
λl′(z − 1)(2n + ln − ln+1) + 2n(l − 2)(λz − ν) (44)
where the C subscript denotes cycling cells, and
l = e(λ−ν)τ (45)
l′ = e(λ−ν)t (46)
Generating function for different phases. We now consider how to extend this reasoning to the overall bottlenecking
process, which in general may involve several phases of quiescent and cycling dynamics with different kinetic parameters.
We begin with the generating function bases gi(z, t) for each regime i. For consistency with the above approach, we label
phases starting from a zero index, so the first phase corresponds to i = 0, and we use imax to denote the label of the final
phase. Then we use
himax = gi(z, t) (47)
hi = gi(hi+1, 0) (48)
Goverall = h
m0
0 , (49)
using induction over the different phases in the way we used induction over different cell cycles above. Here we consider
the changeover between regimes by using the generating function at the start of the incoming phase.
The appropriate generating function bases for quiescent (Eqn. 30) and cycling (Eqn. 44) cells can be written as
gQ(z, t|m0) =
(
AQz +BQ
CQz +DQ
)
, (50)
gC(z, t, n|m0) =
(
ACz +BC
CCz +DC
)
, (51)
with coefficients
AQ = νl
′ − λ (52)
BQ = ν − νl′ (53)
CQ = λl
′ − l′ (54)
DQ = ν − λl′ (55)
AC = 2
nλ(l + l′ − 2)− lnl′(λ+ ν(l − 2)) (56)
BC = l
nl′(λ+ ν(l − 2))− 2n(λl′ + ν(l − 2)) (57)
CC = −λlnl′(l − 1) + 2nλ(l + l′ − 2) (58)
DC = λl
nl′(l − 1)− 2n(λl′ + ν(l − 2)), (59)
using, as before, l = e(λ−ν)τ and l′ = e(λ−ν)t. Note that the cycling coefficients reduce to the quiescent coefficients
when n → 0 and τ → 0. The values of the appropriate A,B,C,D coefficients for a given dynamic phase thus follow
straightforwardly from the kinetic parameters of that phase, with the appropriate choice between quiescent and cycling
parameters being made.
If we now label these coefficients with a subscript denoting the appropriate phase of bottlenecking, so that, for example,
Ai is Eqn. 56 with λi, νi, ni replacing λ, ν, n, we can write:
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himax =
Aimaxz +Bimax
Cimaxz +Dimax
(60)
hi =
Aihi+1 +Bi
Cihi+1 +Di
(61)
goverall = h0. (62)
Following this recursion for n phases of bottlenecking and simplifying the resultant multi-layer fraction gives rise to the
solution
goverall = h0 =
A′z +B′
C ′z +D′
, (63)
where [
A′ B′
C ′ D′
]
=
n∏
i=1
[
Ai Bi
Ci Di
]
(64)
from which Goverall = g
m0
overall follows straightforwardly. The following results will be of assistance:
E(m) =
d
dz
(
A′z +B′
C ′z +D′
)m0∣∣∣∣
z=1
=
m0(A
′D′ −B′C ′)
(
A′+B′
C′+D′
)m0−1
(C ′ +D′)2
(65)
d2
dz2
(
A′z +B′
C ′z +D′
)m0∣∣∣∣
z=1
=
m0(B
′C ′ −A′D′)
(
A′+B′
C′+D′
)m0
(B′C ′(m0 + 1) +A′(2C ′ +D′(1−m0)))
(A′ +B′)2(C ′ +D′)2
(66)
= −
(
A′+B′
C′+D′
)
(A′ +B′)2
(B′C ′(m0 + 1) +A′(2C ′ +D′(1−m0)))E(m). (67)
As Eqns. 52-55 can be thought of as special cases of Eqns. 56-59, we combine Eqns. 56-59 into Eqn. 64, and, simplifying,
we find the following relations:
A′ +B′ = C ′ +D′ =
∏
phase i
2ni(li − 2)(λi − νi) (68)
A′D′ −B′C ′ =
∏
phase i
2ni(li − 2)2lnii l′i(λi − νi)2; (69)
we then immediately obtain
E(m) = m0
∏
i
(
2ni(li − 2)2lnii l′i(λi − νi)2
4ni(li − 2)2(λi − νi)2
)
(70)
= m0
∏
i
2−ni lnii l
′
i (71)
V(m) =
−(B′C ′(m0 + 1) +A′(2C ′ +D′(1−m0)))∏
i 4
ni(li − 2)2(λi − νi)2 E(m) + E(m)− E(m)
2 (72)
leaving us only with the problem of calculating the expression (B′C ′(m0 + 1) + A′(2C ′ + D′(1 − m0))) in the variance
calculation. We were not able to dramatically simplify this expression and so, for clarity, write:
Φ = −(B′C ′(m0 + 1) +A′(2C ′ +D′(1−m0))), (73)
which gives us:
V(m) =
ΦE(m)∏
i 4
ni(li − 2)2(λi − νi)2 + E(m)− E(m)
2. (74)
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We note that Φ is just a notational simplification and is straightforwardly calculable by inserting Eqns. 56-59 into Eqn.
64 then computing Eqn. 73.
Constant population size. For generality, we consider enforcing a constant population size in post-mitotic cells (not
undergoing divisions). This process involves setting λ = ν, so the net gain in mtDNA is zero. If we write λ = ν +  and take
the limit → 0, Eqn. 30 becomes
Gc,post(z, t) =
(
νtz − z − νt
νtz − 1− νt
)m0
. (75)
To enforce a constant mean population size in mitotic cells, it is necessary to balance the expected loss of mtDNA through
repeated divisions with an expected increase during the cell cycle. This balance can be accomplished by setting λ = ν+ ln 2τ .
Writing λ = ν + ln 2τ +  and taking the → 0 limit we obtain
Gc,mito(z, t) =
(
2ντ(z − 1)− 2t/τ (z − 1) ((n1 + 2)ντ + n1 ln 2) + z ln 4
2ντ(z − 1)− 2t/τ (z − 1)(n1 + 2)(ντ + ln 2) + z ln 4
)m0
. (76)
In both these cases, the same approach as above can be used to derive moments of the resulting probability distributions.
Explicit distributions. The probability of observing exactly m mtDNAs of a given type can be found from the generating
function with
P(m, t) =
1
m!
∂m
∂zm
G(z, t)
∣∣∣∣
z=0
. (77)
We can use Leibniz’ rule on a generating function of form G =
(
A′z+B′
C′z+D′
)m0
by setting f ≡ (A′z+B′)m0 , g ≡ (C ′z+D′)m0
and writing
∂mG
∂zm
=
m∑
k=0
(
m
k
)
∂kf
∂zk
∂(m−k)g
∂z(m−k)
(78)
=
m∑
k=0
(
m
k
)
(A′)k(A′z +B′)m0−k
m0!
(m0 − k)! (C
′)m−k(C ′z +D′)(−m0−m−k)(−1)m−k (m0 +m− k − 1)!
(m0 − 1)! . (79)
Enforcing z = 0 and rewriting in terms of a hypergeometric function gives
P(m, t) =
1
m!
(−1)m(B′)m0(C ′)m(D′)−m−m0(m0 +m− 1)!
(m0 − 1)! 2F1
(
−m,−m0; 1−m−m0; A
′D′
B′C ′
)
. (80)
The distribution of heteroplasmy is then given by
P(h) =
∞∑
m1=0
∞∑
m2=0
P(m1, t|(1− h0)m0)P(m2, t|h0m0)I
(
m2
m1 +m2
, h
)
, (81)
where I(h′, h) is an indicator function returning 1 if h′ = h and 0 otherwise. Computing the probability of observing a
given heteroplasmy thus involves a sum, over all mtDNA states that correspond to that heteroplasmy, of the probability of
that state.
The evaluation of hypergeometric functions is more computationally demanding than that of more common mathematical
functions, and the infinite sums at first glance seem intractable. However, in practise and using parameterisations from
our inferential approach, vanishingly little probability density exists at m1,m2 > 5 × 105, corresponding to the biological
observation that mtDNA copy number is very unlikely to exceed this value. Dynamic programming then allows these sums
to be performed straightforwardly.
Finally, the computation of P(m = 0, t) is important in our analysis of the characterisation of key distributions using the
first two moments (see below), where it appears as P(m2 = 0, t), the probability of wildtype fixation. This is relatively
straightforward to address analytically as when m = 0, Eqn. 77 reduces to P(0, t) = Goverall|z=0, which in the notation
above is simply:
ζ ≡ P(0, t) =
(
B′
D′
)m0
, (82)
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where we introduce the notation ζ for fixation probability for later brevity. We could not dramatically simplify the full
expression so we leave it in this form and note that it can be readily calculated (as above) by inserting Eqns. 56-59 into
Eqn. 64 then computing Eqn. 82.
Multiple species and heteroplasmy. The heteroplasmy h = m2/(m1 + m2) is straightforwardly addressable by
considering the above solutions for m1 and m2. We can also consider a more general case, in which we have four species of
mtDNA in our model: wildtype reproducing (m1), mutant reproducing (m2), wildtype sterile (m3) and mutant sterile (m4).
We assume that these species evolve in an uncoupled way with time. The parameter h0, initial heteroplasmy, determines the
initial proportion of mutant genomes: h0 =
m20+m40
m0
, where m0 = m10 +m20 +m30 +m40 is the total initial copy number
of mtDNA. The parameter α determines the proportion of genomes capable of reproducing: α = m10m10+m30 =
m20
m20+m40
.
We compute the time trajectories for all mi then calculate heteroplasmy by setting M1 = m1 + m3, M2 = m2 + m4,
respectively the total numbers of wildtype and mutant mtDNAs, and using Eqns. 24 and 25, where all means and variances
are straightforwardly extracted from the above analysis.
10 Characterisation of distributions of important quantities with moments
We are interested in the probability with which heteroplasmy h exceeds a certain threshold value h∗. This probability can
be computed using Eqn. 81 above, but the large sums of hypergeometric functions suggest that a simpler approximation of
the heteroplasmy distribution may be desirable, both for computational simplicity and intuitive interpretability. We here
explore how well distributions of copy number and, importantly, heteroplasmy are characterised by quantities that are easily
obtained from our analytic approaches without large summations: specifically, low-order moments E(m),V(m), and fixation
probabilities P(m = 0).
For moderate initial heteroplasmy 0.7 > h0 > 0.3, all distributions are well matched by the Normal distributions computed
using the first two moments E(m) and V(m). This match begins to fail as initial heteroplasmy decreases or increases to the
extent where fixation of one mtDNA type becomes likely. The resultant non-negligible probability density at h = 0 and/or
h = 1 represents a truncation point which forces skew on the distributions (particularly P(h)) and weakens the Normal
approximation.
We can make progress by considering P(h) to be a weighted sum of a truncated Normal distribution N ′(µ, σ2) (truncated
at 0, 1; and with currently unknown parameters µ, σ) and two δ-functions at h = 0 and h = 1 representing the fixation
probability of wildtype and mutant mtDNA respectively. If we write PN ′(h) for the probability density at h of such a
truncated Normal distribution, we have:
P(h) = (1− ζ1 − ζ2)PN ′(h) + ζ1δ(h) + ζ2δ(h− 1), (83)
where ζ1 = P(m2 = 0, t) is the fixation probability of the wildtype and ζ2 = P(m1 = 0, t) is the fixation probability of the
mutant, expressions for which were computed previously in Eqn. 82. Knowledge of the parameters µ, σ that describe the
truncated Normal part of this distribution will then provide us with a better estimate of P(h).
We can use the relations E(h) =
∫
hP(h) dh and V(h) =
∫
h2P(h) dh− E(h)2. As δ(h) provides a nonzero contribution to
these integrals only when h = 0, the contribution from this part of P(h) is always zero; then,
E(h) =
∫
h ((1− ζ1 − ζ2)PN ′(h) + ζ2δ(h− 1)) dh (84)
= (1− ζ1 − ζ2)E(N ′) + ζ2 (85)
V(h) =
∫
h2 ((1− ζ1 − ζ2)PN ′(h) + ζ2δ(h− 1)) dh− E(h)2 (86)
= (1− ζ1 − ζ2)
(
V(Nh>0) + E(Nh>0)2
)− E(h)2 + ζ2 (87)
where E(N ′), V(N ′) are respectively the mean and variance of the truncated Normal distribution, and in the final line we
have used the fact that V(N ′) = ∫ h2PN ′(h) dh− E(N ′)2.
Results are known [74] for moments of the truncated Normal distribution:
E(N ′) = µ+ σ f(α1)− f(α2)
F (α2)− F (α1) (88)
V(N ′) = σ2
(
1− α1f(α1)− α2f(α2)
F (α2)− F (α1) −
(
f(α1)− f(α2)
F (α2)− F (α1)
)2)
(89)
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Figure 9: Comparison of truncated Normal approximation with exact heteroplasmy distribution. Representations of heteroplasmy
distributions at a time t = 21dpc, with various starting heteroplasmies, using (as an example) the maximum likelihood parameterisation emerging
from the inference procedure in the main text. Dark lines and bars show exact distributions from Eqn. 81; pale lines and bars show distributions
arising from the truncated Normal distribution described in the text.
where, in our case (with truncations at h = 0 and h = 1) α1 = −µ/σ, α2 = (1−µ)/σ and f(x) = (
√
2pi)−1 exp(−x2/2) and
F (x) = 12 (1 + erf(x/
√
2)) are respectively the p.d.f. and c.d.f. of the standard Normal distribution. Given these expressions,
we wish to invert these Eqns. 85 and 87 to find µ and σ, the parameters underlying the truncated Normal distribution,
given E(h), V(h) and ζ1,2 = P(m2,1 = 0), which we can compute (see below). We have not been able to find an analytic
solution for these equations; however, numerically solving these equations is computationally far cheaper than performing
the numeric simulations required to better characterise the real distribution. We then obtain an expression for P(h), which
well matches the exact distribution derived using Eqn. 81 (see Fig. 9).
Threshold crossing. The probability of crossing a threshold heteroplasmy h∗ with time is simply given by the probability
density in the region h > h∗. We can then use the result
P(h > h∗) = (1− ζ1 − ζ2)
(
1− 1
2
(
1 + erf
(
(h∗ − µ)/
√
2σ2
)))
+ ζ1(1− δ(h∗)) + ζ2(1− δ(h∗ − 1)), (90)
for threshold crossing, which follows straightforwardly from considering the integrated density of the model distribution
(Eqn. 83) of h above h∗, with parts from the error function representing the definite integral of the truncated Normal part
of the distribution, with additional terms from wildtype fixation (if h∗ 6= 0) and mutant fixation (if h∗ 6= 1).
Inferring embryonic heteroplasmy. The probability that a sample measurement hm came from an embryo with
heteroplasmy h0 can be found from Bayes’ Theorem:
P(h0|hm) = P(hm|h0)P(h0)P(hm) . (91)
We assume a uniform prior distribution P(h0) = ρ on embryonic heteroplasmy (though this can be straightforwardly
generalised). P(hm) is given by the integral over all possible embryonic heteroplasmies of making observation hm, so we
obtain
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P(h0|hm) = ρP(hm|h0)∫ 1
0
dh′0ρP(hm|h′0)dh′0
(92)
=
(1− ζ1 − ζ2)N ′(hm|µ, σ2) + ζ1δ(hm) + ζ2δ(hm − 1)∫ 1
0
dh′0 ((1− ζ1 − ζ2)N ′(hm|µ, σ2) + ζ1δ(hm) + ζ2δ(hm − 1))
, (93)
where the µ, σ2 moments characterising the truncated Normal distribution are found numerically as above (for each h′0
value in the integrand, which is performed numerically); and ζ1, ζ2 are also functions of h0.
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